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ABSTRACT OF DISSERTATION

THE RELATIONSHIP BETWEEN MODIFIABLE LIFESTYLE FACTORS AND
MUSCLE LIPID DEPOTS IN OLDER ADULTS

Muscle health declines with age, influencing both muscle strength and
performance. Modifiable lifestyle factors may mitigate muscle dysfunction by
altering muscle lipid depots. Vitamin D status, dietary intake, and physical activity
each play a role in muscle health during aging. Low vitamin D status (measured
as 25(OH)D) is prevalent among older adults and has been associated with
functional limitations and impaired physical performance. Previously, 25(OH)D
concentrations were inversely associated with extramyocellular lipid (EMCL) and
our lab observed a significant positive relationship between 25(OH)D
concentrations and IMCL. Studies have shown mixed results regarding the
effects dietary fat intake interventions have on muscle lipid depots. It is well
established that exercise contributes to improved muscle health, but to date
studies have not examined the relationship between daily physical activity levels,
muscle lipid depots, and local muscle tissue hemodynamics. We used novel noninvasive technology to measure gastrocnemius muscle lipid depots (Proton
Magnetic Resonance Spectroscopy) and monitor local muscle tissue
hemodynamics during a foot plantar flexion exercise (Near Infrared/Diffuse
Correlation Spectroscopy). The first aim was to further elucidate the relationship
between 25(OH)D concentrations, physical function, and muscle lipid depots. We
also examined 25(OH)D concentrations and muscle lipid depots differences in
older adults with varied body mass index (BMI) and physical activity levels. We
observed a negative relationship between 25(OH)D concentrations and EMCL. In
females, greater 25(OH)D concentrations and lower EMCL were significant
predictors of faster Four Square Step Test times, independent of BMI and age.
Greater EMCL and IMCL content were observed with increased BMI, but
statistical significance was not reached. The second aim was to retrospectively
examine the relationship between dietary fat intake and muscle lipid depots in
participants enrolled in a double-blinded placebo-controlled trial. We also
investigated the relationship between physical activity levels and local muscle
tissue hemodynamics. Increased dietary fat intake ratio of polyunsaturated to

saturated fatty acids (PUFA:SFA) and study intervention (7 days of aerobic
training) were the best predictors of lower IMCL content, independent of age,
BMI, and physical activity. Compared with individuals with lower physical activity
levels, individuals that reported greater physical activity had lower relative blood
flow and relative oxygen consumption during and after a foot plantar flexion
exercise. Together these findings suggest that increased physical activity,
consumption of greater PUFA:SFA, and maintenance of sufficient 25(OH)D
concentrations may have favorable effects on muscle lipid depots and contribute
to the preservation of muscle health.

KEYWORDS: vitamin D, dietary fat intake, physical activity, intramyocellular lipid,
extramyocellular lipid
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Chapter 1: Background
1.1 Vitamin D: Overview
Vitamin D is a fat-soluble secosteroid, traditionally associated with bone
health [1, 2]. Vitamin D has existed on the Earth for at least 500 million years and
caused a 270-year scientific inquiry for the cure of rickets, a disease first
recognized in the 1650s [2]. The rickets epidemic emerged during the Industrial
Revolution, in temperate zones, where the pollution from factories blocked the
sun’s ultraviolet rays (UV) [2]. By the late 19th and early 20th century, rickets, the
incomplete calcification of the epiphyseal closure in children [3], affected more
than 80% of children living in United States’ and European cities [4]. While some
cases of rickets are related to hereditary syndromes, renal disease, or use of
medication, outbreaks of rickets predominantly stem from nutritional insufficiency
[5]. Such nutritional insufficiency occurs when metabolites of vitamin D are
deficient and less commonly can result from dietary deficiency of calcium or
phosphorus.
In 1921 Hess and UInger reported UV radiation was an effective treatment
for rickets [2]. Today rickets remains rare in developed nations due to increased
awareness and consumption of vitamin D fortified foods. However, low vitamin D
status in adults is prevalent and has become a worldwide epidemic. Analogous to
rickets in children, failure of osteoid to calcify in adults is termed osteomalacia.
Vitamin D is not only important in optimal bone health, reducing the risk of
osteomalacia and osteoporosis in adults [1], but low levels have also been
implicated in many acute and chronic diseases such as cancer, diabetes, and
cardiovascular diseases [6, 7]. More recently, maintaining sufficient vitamin D
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status has been associated with improved musculoskeletal health [8] affecting
muscle strength and size [7]. Age-related muscle mass decreases have been
associated with increased risk for fractures and falls [9]. Concurrently, the high
prevalence of vitamin D deficiency and insufficiency in the growing aged
population leaves older adults susceptible to decreased muscle function and
subsequently increased risk for falls. Therefore, it is imperative to effectively
measure, assess, and understand the role vitamin D plays on skeletal muscle in
older adults.
1.1.1 Vitamin D Measurements
In the human body, vitamin D exists in two main forms that differ in side
chain structure. One of the forms is cholecalciferol (vitamin D3) which is mainly
synthesized endogenously through skin exposure to UVB radiation. In addition,
small amounts of vitamin D3 can also be obtained from dietary animal sources
such as egg yolk and oily fish [2]. Ergocalciferol (vitamin D2) is the other form
that is found in plants and yeast. Traditionally, vitamin D2 and D3 were thought to
be equipotent; however, human studies have shown that raising 25-hydoxy
vitamin D (25(OH)D) concentrations with vitamin D3 is more than 2-fold effective
[2, 10]. Vitamin D2 is less effective in raising 25(OH)D concentrations because of
the differences in binding affinities for vitamin D bind protein (VDBP) between
vitamin D2 and D3. Vitamin D2 has a lower binding affinity to VDBP resulting in a
shorter circulating half-life and increased circulating clearance rate than that of
vitamin D3 [10]. It is vital to note that hepatic 25-hydoxylase has a higher affinity
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for vitamin D3, converting it to 25(OH)D3 five times faster than the rate of
conversion from vitamin D2 to 25(OH)D2.
The vitamin D metabolite, 25(OH)D, is a diagnostic measure used to
evaluate vitamin D status. Since the mid-1970s high performance liquid
chromatography (HPLC) has been the gold standard for 25(OH)D assay as it
provides the ability to quantify both forms (D2 and D3) [11]. Although 25(OH)D is
the inactive form of vitamin D, it is the major circulating metabolite with a half-life
of 2-3wks [12]. The highest concentration of 25(OH)D can be found in plasma
and 25(OH)D is stored in the adipose and muscle tissues. Eighty-five percent of
the inactive form 25(OH)D and the active form 1,25-dihydroxyvitamin D
(1,25(OH)D) is bound to VDBP, 10-15% is bound to albumin, and 0.03% is free
or unbound [13]. Although the majority of vitamin D is bound, the unbound
portion of 1,25(OH)D, or active form, is able to exert biological activity, following
the principle of the free hormone hypothesis [14]. The free hormone hypothesis
states that unbound hormones are available to exert biological activity while
hormones bound to proteins are relatively inactive. VDBP concentrations can be
altered with pathological conditions and vary between individuals, this in turn can
affect circulated 25(OH)D concentrations [14-17]. Researchers suggest that
VDBP should be measured and assessed as VDBP concentrations could be a
confounding variable when interpreting 25(OH)D concentrations [14].
The biologically active form of vitamin D is calcitriol, 1,25(OH)D, which is
primarily produced in the proximal tubules of the nephron in the kidneys.
Calcitriol is an inappropriate measure of vitamin D status due to its short half-life
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of 4-6 hours and the circulated form that is 1,000 fold less than 25(OH)D [11].
Although 1,25(OH)D is an inappropriate measure of vitamin D status in healthy
individuals, there are disease states in which it may be appropriate to measure
1,25(OH)D. For example, patients with sarcoidosis, exhibit increased 1,25(OH)D
concentrations as the immune cells produce calcitriol resulting in vitamin D
toxicity and hypercalcemia. During chronic renal failure the disorder or the
absence of 1-alpha-hydroxylase, enzyme located in the kidneys responsible for
the conversion of 25(OH)D to 1,25(OH)D, results in reduced 1,25(OH)D
concentrations [18]. Disease states can affect vitamin D measures; therefore, it is
important to fully understand vitamin D metabolism and consider which vitamin D
metabolites are necessary to assess.
1.1.2 Vitamin D Metabolism
Vitamin D can be synthesized cutaneously through skin exposure to UVB
rays or through dietary intake of natural and fortified foods or supplements. Provitamin D3 (7-dehydrocholesterol) is located in the epidermal skin layer and in
response to heat-induced UVB radiation undergoes isomerization to form previtamin D3. Pre-vitamin D3 can 1) bind to the VDBP in the bloodstream and be
transported to the liver where it undergoes hydroxylation or 2) be converted to
tachysterol and lumisterol [2]. Excess exposure to UVB radiation results in the
continuous production of the inactive compounds, tachysterol and lumisterol.
Further, the inert compounds act as a reservoir and therefore can be converted
back into pre-vitamin D3. This mechanism safeguards from sun-induced vitamin
D toxicity. Conversely, vitamin D derived from natural foods, fortified foods and/or
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supplements (vitamin D2 and D3) can be incorporated into chylomicrons,
released into the lymphatic system, and then bound to VDBP in venous
circulation. A small portion of the dietary vitamin D is extracted by adipose tissue
and muscle; however, the remainder of dietary vitamin D and the most of the
endogenously synthesized vitamin D is transported to the liver [2].
In the liver, pre-vitamin D is hydroxylated by the enzyme 25-hydroxylase
(also known as cytochrome p450) and converted to 25(OH)D (calcidiol). Next,
25(OH)D is 1-hydroxylated by 25-hydroxyvitamin D 1-hydroxylase (1 alphaOHase), located primarily in the proximal tubules of the kidney, resulting in the
active form 1,25(OH)D (calcitriol) [2, 19]. Although primarily the enzyme,1 alphaOHase, plays a role in the kidneys and converts calcidiol to the bioactive form
calcitriol, the enzyme is also present in various tissue cells such as in
keratinocytes, immune cells, myocytes, and osteoblasts which allows for vitamin
D signaling at a local, tissue specific level [20].
Serum parathyroid hormone (PTH) plays an important role in regulating
the conversion of calcidiol to calcitriol. Calcium-sensing receptors located on
chief cells in the parathyroid glands are stimulated during low serum calcium
concentrations, to release PTH. Conversely, when calcium concentrations are
high, reverse inhibition of parathyroid gland receptors occurs [21]. In addition, in
the kidney, PTH can increase the activity of 1 alpha-OHase, which in turn
increases the production of calcitriol. Calcitriol can act in the small intestine by
binding to the retinoid-X receptor (RXR) to increase the transcription of epithelial
calcium transporter proteins and calbindin. Calcium transporters and binding
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proteins increase calcium absorption, raising serum calcium concentrations [2].
Further, PTH can bind to the PTH1 receptor located on osteoblasts. Upon
prolonged PTH exposure, RANKL (located on the osteoblasts) binds to RANK
(located on the osteoclasts) to stimulate bone resorption resulting in the release
of calcium from the bone into the serum [22]. Conversely, intermittent exposure
of PTH and higher calcitriol concentrations cause osteoblast proliferation,
increases in bone mineralization, and decreased serum calcium concentrations.
During high 25(OH)D concentrations, a negative feedback mechanism
inhibits 25-hydroxylase decreasing further production of 25(OH)D in the liver [2].
Further, high 1,25(OH)D concentrations can inhibit 1 alpha-OHase reducing
calcitriol synthesis in the kidney. Also, 1,25(OH)D can be degraded by 24-OHase
to 1,24,25(OH)D (calcitroic aid) which undergoes biliary excretion.
1.1.3 Vitamin D Sources
Most notably, vitamin D can be obtained through UVB ray exposure. It is
recommended that exposing the arms, legs, face, or back without sunscreen for
5-30 minutes, at least 2 times a week between the hours of 10:00AM and
3:00PM, would provide adequate vitamin D synthesis [23]. As a result of 5-10
minutes of UVB exposure, 3,000IU of vitamin D3 can be cutaneously synthesized
[24]. Individuals residing at latitudes above 35°N or below 35°S, during the
months of November-March, synthesize minimal vitamin D through UVB ray
exposure [25].
The Recommended Dietary Allowance (RDA) for individuals between 1-70
years of age is 600IU/d and for individuals older than 70 is 800IU/d [23, 26]. The
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higher levels for older adults is recommended as decreases in intestinal
absorption occur with aging [27]. Natural foods containing higher vitamin D levels
include oily fish such as salmon (500-1000IU/3.5oz serving) and UVB-exposed
mushrooms (~100IU/3.5oz serving) [24, 25]. To a lesser extent, foods such as
beef liver and egg yolks also contain vitamin D. Fortified foods in the United
States including milk, juice, and some cheeses and yogurts typically contain
100IU/serving [23, 25, 28].
Dietary vitamin D supplements can be consumed to increase and maintain
25(OH)D concentrations. Current clinical guidelines for treatment of vitamin D
deficiency is to supplement with vitamin D for 8wks (50,000IU/wk or 6,000IU/d),
to achieve a concentration of 25(OH)D>30 nanograms/milliliter (ng/mL), followed
by maintenance therapy of 1,500–2,000IU/d [27]. Heaney et al. [29] observed a
20ng/mL and 30ng/mL increase in 25(OH)D in healthy overweight participants
after administering 50,000IU/wk for 4 and 6wks, respectively. In addition, Ekwaru
et al. [29] recommended 2-3 times greater vitamin D supplementation for obese
individuals and 1.5 times greater for overweight individuals relative to normal
weight individuals. These differences in vitamin D supplementation
recommendations are a result of genetic and modifiable lifestyle factors that
contribute to vitamin D status.
1.1.4 Genetic Polymorphisms in VDBP that Modulate Vitamin D Status
Genetic polymorphisms are the genetic variations that occur between
individuals. VDBP variants are due to the polymorphisms in the VDBP gene
guanine and cytosine (GC) and are defined as GC1F, GC1S, and GC2 [30].
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Genetic polymorphism in VDBP effect vitamin D status; therefore, previous
research has investigated the role of physiologic factors on VDBP and
subsequently on vitamin D status in pathologic conditions.
Pathologic conditions such diabetes and cancer may alter VDBP and
25(OH)D concentrations. In Type I diabetic patients with nephropathy, an
increase in urinary loss of VDBP contributes to lower 25(OH)D concentrations
[31]. Conversely, the role of VDBP in 25(OH)D concentrations and cancer risk is
still emerging. VDBP has not been directly linked with increased risk of cancer,
but as 25(OH)D is modulated by VDBP researchers suggest that examination of
both 25(OH)D and VDBP are necessary to understand the association observed
between vitamin D status and cancer risk [14, 32].
Physiological factors such as sex and race affect VDBP and 25(OH)D
concentrations. Studies suggest that VDBP concentrations are greater in females
than males potentially due to the effect of estrogen stimulating VDBP synthesis
[14]. Although estrogen decreases with menopause, Kaeslin et al. [33] observed
greater 25(OH)D concentrations in postmenopausal women compared with
aged-matched males potential due to higher VDBP concentrations. Also studies
have shown VDBP genetic polymorphisms are associated with race and could
alter VDBP levels and binding affinity [14, 15]. The functional significance of
these genetic polymorphisms are not yet completely understood, but VDBP can
alter circulating 25(OH)D concentrations and should be considered as a potential
confounding factor in the interpretation of 25(OH)D concentrations.
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One study included a cohort of African American (n=1,181) and White
(n=904) middle-aged adults [15]. The authors observed that African Americans
had consistently lower 25(OH)D concentrations and lower VDBP compared with
Whites; however, the estimated bioavailable 25(OH)D was similar. The
bioavailable or free 25(OH)D is the circulating vitamin D that is not bound to
VDBP. These data suggest that low 25(OH)D concentrations combined with low
VDBP may not indicate vitamin D deficiency. Additionally, differences in race and
protein variants have been observed. African Americans and Asians are more
likely to carry the GC1F VDBP. GC1F has the highest affinity for 25(OH)D and is
associated with low VDBP. Conversely, Whites are more likely to carry GC1S
and GC2. GC2 has a lower affinity for 25(OH)D and is associated with higher
VDBP concentrations [14]. Therefore, 25(OH)D concentrations are in part due to
the genetic variation in VDBP, in which lower VDBP with greater binding affinity
may be a genetic trait to protect African Americans from vitamin D deficiency
[15].
Lutsey et al. [34] provided another example of genetic variance influencing
pathology between races. This study examined the association between
25(OH)D, VDBP, and heart failure among Whites and African Americans (total
n=12,215). The authors observed that lower 25(OH)D concentrations were
independently associated with increased risk of developing heart failure but only
in White individuals. However, in both White and African American individuals,
who were genetically predisposed to higher VDBP, lower 25(OH)D was
associated with greater risk of heart failure. With higher VDBP a greater portion
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of 25(OH)D was bound and subsequently less vitamin D was bioavailable
contributing to increased cardiovascular risk.
A more recent study by Alzaman et al. [17] examined the effects of vitamin
D supplementation (2,00IU/d or 4,000IU/d for 16wks) on bound and free
25(OH)D between African American (n=57) and White (n=151) adults with pre- or
well-controlled diabetes. Prior to supplementation, the authors observed that
African Americans had lower total 25(OH)D but similar free 25(OH)D
concentrations compared with Whites. In both races, an increase in free and
bound 25(OH)D post-supplementation was observed. Further, lower VDBP
concentrations were observed in African Americans when a monoclonal antibody
immunoassay, a more widely used technique to measure VDBP was employed.
However, this technique was scrutinized as falsely lowering VDBP values in
African Americans due to the differentiation against a VDBP variant that is more
common in African Americans. In light of this, the authors applied a polyclonal
antibody technique, which resulted in no significant racial differences between
VDBP concentrations. In addition, Nielson et al. [16] examined these techniques
with a larger sample size (African American n=101; White n= 919). The authors
confirmed that previous findings of racial differences in VDBP concentration may
be attributed to the monoclonal assay bias as no racial differences exist when
alternative methods were employed. Due to discrepancies between
methodologies used, further investigation is warranted to assess if racial
differences in VDBP concentrations truly exist.
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Together these studies provide evidence to the importance of VDBP
genetic polymorphisms and the effects of both pathological and physiological
factors on VDBP. Disease states can alter the production of VDBP which
modulated 25(OH)D concentrations. As low 25(OH)D have been associated with
multiple diseases, the combination of examining both 25(OH)D and VDBP is
important to the understanding of the effects of vitamin D on disease risk.
Further, difference among opposite sexes exists, in which higher VDBP
concentrations are typically observed in females compared with males. Racial
differences in VDBP variants between African Americans (GC1F) and Whites
(GC1S and GC2) exist. African Americans have lower VDBP but higher binding
affinity to 25(OH)D compared with Whites and as a result the bioavailability of
25(OH)D concentrations is similar between races. Due the racial variability in the
VDBP gene, it is crucial that the techniques used to assess VDBP and free and
bound 25(OH)D are taken into consideration.
1.1.5 Factors that Modulate Vitamin D Status
Considerable amount of the vitamin D requirements can be met through
sensible UVB exposure, whereas very few foods naturally contain vitamin D and
fortified foods typically only contain 100IU/serving [28]. Multiple factors play a
role in the ability to synthesize vitamin D cutaneously. Factors such as time of
day, season of the year, and latitude play an important role since the zenith angle
of the sun changes with Earth’s rotation. The solar zenith angle becomes more
oblique early or late in the day. Likewise, the angle is more oblique during the
months of November-March and below 35°S or above 35°N [25]. At a more
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oblique zenith angle the photons must travel longer distances through the ozone
layer which make UVB rays more susceptible to absorption by the ozone, thus
decreasing the amount of photons reaching the Earth’s surface [25]. In addition,
the UVB rays that are not absorbed in the ozone layer can be absorbed by air
pollution or clouds, reducing UVB energy by 50-60% [23].
The skin is comprised of the superficial thinner layer, epidermis, and the
deeper layer, dermis. UVB rays (290-315nm) penetrate the epidermal layer,
while UVA rays are longer in wavelength (320-400nm) and penetrate deeper into
the dermis. Greatest 7-dehydrocholesterol concentrations are located in the
epidermal layer of the skin and absorb UVB light at 290-320nm, thus UVB
radiation is effective at converting 7-dehydrocholesterol to pre-vitamin D3.
Other factors such as sunscreen and sunblock use and skin melanin
content can reduce the skin’s ability to produce vitamin D [28]. When applied as
directed, sunscreen with a sun protection factor as low as 8 can reduce 25(OH)D
by approximately 20ng/mL [2]. Melanin is derived from tyrosine and is
responsible for the pigmentation of human skin, pupils, and hair color. The
natural selection hypothesis states that lighter skin color, at higher latitudes with
lower UVB radiation, evolved to optimize and facilitate vitamin D production [35].
The Fitzpatrick scale can be used to estimate the response of various skin types
to UVB exposure ranging from Type I (score 0-6, always burns and never tans)
to Type VI (score 35-36, never burns or tans) [36]. Individuals with greater scores
on the Fitzpatrick scale have more melanin, which can act as a natural
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sunscreen. Individuals with skin Type I are 6-times more efficient at synthesizing
vitamin D from UVB rays compared to individuals with a skin Type VI.
With an increase in aging, atrophic skin changes occur and the thickness
of the epidermal skin layer is reduced. 7-dehydrocholesterol is located in the
epidermis and concentrations decrease with aging due to the thinning of the
epidermal skin layer. In older adults, 7-dehydrocholesterol concentrations are
two-fold lower compared with younger adults. With the reduction in pro-vitamin D
concentrations, the ability to cutaneously form pre-vitamin D3 is decreased,
subsequently leading to an overall decrease in 25(OH)D concentration [28]. Past
studies have suggested that intestinal absorption of dietary vitamin D decreases
with age; however, recent studies observed only minor structural changes to the
small intestines that do not significantly contribute to altered vitamin D absorption
[27].
Due to the lipophilic nature of vitamin D3, adiposity also plays a role in the
bioavailability of circulating 25(OH)D. The volumetric dilution and greater
sequestration into the adipose tissue hypotheses have been attributed to the
following observed associations [37-42]. In one meta-analysis, the prevalence of
vitamin D deficiency was 24-35% greater in the overweight and obese individuals
compared with the normal weight individuals [43]. Previously, our lab examined
the role body composition and BMI play in 25(OH)D response after a 6-month
vitamin D supplementation regimen (4,000IU/d) in athletes [40]. We observed a
trend between lower fat mass and a lower decrease in 25(OH)D concentrations.
Also a significant negative correlation between BMI and 25(OH)D change in the
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supplement group was noted. Interestingly, BMI ranged from 18.5 to 26
kilograms/meters2 (kg/m), with only 2 of 32 participants classified as overweight,
suggesting that diminished 25(OH)D concentrations post-supplementation
extended beyond overweight and obese individuals and included individuals in
the normal BMI category. A recent systematic review [39] examined the effect of
weight loss on 25(OH)D. The authors pooled randomized and non-randomized
trials and observed a small, significant increase in 25(OH)D concentrations with
weight-loss; however, a dose-response relationship was not detected. These
studies suggest that increased adiposity lowers 25(OH)D concentrations,
potentially increasing the risk of vitamin D deficiency or insufficiency in
individuals with greater adiposity.
1.1.6 Controversies in Vitamin D Recommendations
To date, RDA requirements for vitamin D, UVB exposure, and 25(OH)D
concentrations for optimal health remain controversial. Although the RDA
requirements are set at 600-800IU/d for adults [23], many scientists have stated
that this amount is inadequate and should be increased to at least 800-1,000IU/d
[25]. The Endocrine Society suggests levels of 1,500-2,000IU/d may be
necessary in order to raise 25(OH)D concentrations above 30ng/mL [27].
Furthermore, the National Institutes of Health Office of Dietary Supplements
states that no vitamin D synthesis through sun exposure can occur without
increased risk of skin cancer [23]. Conversely, due to the short time exposure to
UVB radiation required to acquire adequate vitamin D levels, researchers
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suggest that sensible sun exposure would lead to minimal risk in the
development of skin cancer [28, 44].
Similar to dietary intake and UVB exposure recommendations, a
controversy exists about defining 25(OH)D cut-offs for deficiency, insufficiency,
and sufficiency. Vitamin D deficiency has been set at 25(OH)D<20ng/mL, a cutoff that is considered inadequate for bone health [24, 26, 27]. Vitamin D
insufficiency is typically considered as 20-29ng/mL; however, some researchers
suggest that the insufficiency range should be expanded to a concentration
threshold of 32ng/mL as it has been established that this concentration increases
intestinal calcium transport by 45-65% [6, 14, 24, 44-46]. Some researchers
identifying sufficient vitamin D status starting at 30ng/ml [23], 32ng/mL [14], or
more recently 40ng/mL [27, 28, 47, 48]. These concentrations are considered
beneficial beyond maintaining optimal bone health and potentially promoting
muscle health.
Similarly, the upper limit for what is considered healthy is surrounded by
controversy. The National Institutes of Health [23] identifies a 25(OH)D
concentrations of >50ng/mL as being associated with potentially adverse effects.
Conversely, the Endocrine Society practice guidelines suggest that
concentrations up to 150ng/mL are safe and do not induce hypercalcemia [27].
The tolerable upper intake level set by the National Institutes of Health is
4,000IU/d for individuals older than 9 years of age [18]. Excessive vitamin D
intake can result in increased calcium levels, which may lead to an increased risk
of kidney stones, tissue calcification, and damage to the heart and blood vessels.
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However, individuals supplemented with 10,000IU/d for a period of 5-months
reported no adverse events [23]. Further, Drincic et al. [41] suggested that
normal weight individuals need 4,000IU/d and 5,000IU/d to sustain a 25(OH)D
concentration of 32ng/mL and 40ng/mL, respectively.
The recommendations for dietary intake, UVB exposure, and cut-off
parameters for adequate vitamin D status vary between governmental
recommendations and the recommendations of researchers. Due to these
controversies, the prevalence of vitamin D deficiency reported in populations
such as in older adults varies, as there is no standardized definition of vitamin D
deficiency across all studies. Further, in studies examining the beneficial effects
of vitamin D supplementation on health, varying vitamin D supplementation
dosages are used leading to inconclusive data. The need for standardized
definitions and cut-offs across the scientific community and governmental
regulating bodies is both topical and essential for effectively addressing the issue
of increased prevalence of vitamin D deficiency. For the purpose of this
dissertation vitamin D status will be defined as deficiency set at
25(OH)D<20ng/mL, insufficiency set at 20-30ng/mL, and sufficiency
25(OH)D≥30ng/mL.
1.1.7 Vitamin D Status in Older Adults
Vitamin D deficiency and insufficiency is a worldwide epidemic and there
is an especially high prevalence of low vitamin D status in older adults [24]. In
part, this high prevalence can be attributed to cutaneous decreases in vitamin D
synthesis due to decreased concentration of 7-dehydrocholesterol in the
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epidermal skin layer. Likewise, disease states and physiological changes can
alter vitamin D pharmacokinetics (the effect the body has on vitamin D) and
pharmacodynamics (the effect vitamin D has on the body) [46]. One physiological
example is the decrease of calcitriol production due to decreasing renal function
observed with aging. Studies suggest that 40 to 100% of older communitydwelling adults are vitamin D deficient [24, 49, 50]. In part, this wide range of
vitamin D deficiency is due to diverse cut-off parameters set for vitamin D
deficiency and heterogeneity of both physiological and lifestyle factors in the
older population.
It is justified to distinguish between community-dwelling and
institutionalized older adults. Typically, community-dwelling adults are younger,
more independent, and have a lower prevalence of vitamin D deficiency primarily
due to increased time spent outdoors [49, 51]. A decline in bone and muscle
mass occur with aging, which can result in increased nursing home admission
and hospitalizations [50]. With institutionalization, a decrease in mobility and time
spent outdoors further contributes to lower vitamin D status. The concern of low
vitamin D status in older adults has been aimed at maintaining adequate vitamin
D and calcium levels to reduce the risk of falls and bone fractures [52]. However,
bone and muscle tissues are functionally linked. Vitamin D can exert its influence
beyond the bone by acting on skeletal muscle, potentially preserving muscle
strength and function during aging, leading to an overall decrease in risk of falls
and fractures [49].
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1.1.8 Muscle Health and Aging Physiology
Sarcopenia, defined as the age-related loss of muscle mass, is greatest
after 50 years of age, with rates of muscle mass decline at 12-15% per decade.
Muscle loss effects men and women differently, with men experiencing greater
loss than women potential due to decreases in testosterone with aging [53]. The
progressive muscle wasting with aging decreases physical function and
increases the risk of falls leading to a loss of independence and an increase in
morbidity and mortality [9, 49]. As the population of 65 year olds is expected to
double in the next 30 years, interest in combating sarcopenia and improving
quality of life are rising [54].
Loss of muscle mass leading to decreased muscle strength and function is
a multifaceted issue. Histologically, decreases in the amount and size of
mitochondria and a decline in the number of Type I (slow twitch) and Type II (fast
twitch) muscle fibers is seen with aging. Both increased inflammation and
lipotoxicity along with decreased neuronal stimulation, muscle protein synthesis,
and capillary blood flow occur with aging further contributing to sarcopenia [9].
Studies have shown that increased ectopic fat depots in muscle are associated
with reduced strength and performance [55, 56]. These factors combined limit the
ability of the muscle to generate power with age and compromise muscle
function, which lead to a decrease in quality of life. It is evident that modifiable
lifestyle factors such as aerobic and resistance training and nutrition can play a
significant role in preserving or limiting the progression of muscle mass loss [57].
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1.1.9 The Role of Vitamin D in Muscle Physiology during Aging
Generally, low vitamin D status has been associated with functional
limitations and poor physical performance in older adults [38, 49, 50]. However,
randomized controlled trials and observational studies have yielded mixed
results. A recent systematic review and meta-analysis concluded that vitamin D
supplementation had limited influence on muscle strength and mobility
preservation in older adults [49]. However, studies included in the analysis widely
varied in type of vitamin D supplementation (D2 or D3), dosage of vitamin D, and
the combination of vitamin D supplementation with calcium. In addition, functional
performance and strength tests varied between assessed interventions.
Therefore, the authors suggested that the small sample size among individual
trials and heterogeneity of studies preclude the ability to form a fixed conclusion
[49]. A 3-year longitudinal study reported that deficient vitamin D status
(25(OH)D<20ng/mL) was associated with a 2-fold increased risk of muscle mass
loss compared with sufficient vitamin D status (25(OH)D>30ng/mL) in older
adults [58]. In a sample of 20 older adults between the ages of 65-85, our lab
observed a significant positive relationship between higher 25(OH)D
concentrations and faster Four-Square-Step Test times (FSST); however we did
not see a relationship between vitamin D status and other physical performance
(gait speed, timed up and go, and 5-times sit-to-stand) or strength measures [59].
An observational study that included over 2,000 older adults suggested that
vitamin D deficiency was associated with weaker handgrip strength and lower
performance measures (gait speed, 6-minute walk, and 5-times sit-to-stand)
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when compared with individuals with 25(OH)D>40ng/mL [60]. Higher
concentrations of 25(OH)D were also associated with better lower extremity
function (8-foot walk and sit-to-stand test) in both inactive and active adults 60
years of age or older [61]. Lower-extremity function improved from 3.9 to 5.6%
from the lowest to the highest 25(OH)D quintile. Further this study suggests that
it may be advantageous to reach and maintain 25(OH)D concentrations between
36.5-40ng/mL as these levels were associated with better lower-extremity
function. Other research also suggests that 25(OH)D concentrations greater than
40ng/mL may be beneficial for muscle health [27, 28, 47]. Shuler et al. [47]
reviewed the role vitamin D plays in athletes, the authors’ suggest that decreased
risk of stress fractures occurs at 40-50ng/ml and potential athletic performance
enhancement occurs at 50-60ng/mL. In addition, due to variability in assays used
to assess 25(OH)D, Hossein-nezhad et al. [28] suggests that maintenance of
25(OH)D between 40-60ng/mL is ideal. Similarly, the Endocrine Society suggests
that maintenance of 40ng/mL ensures that the individuals’ true 25(OH)D
concentrations is greater than 30ng/mL [27]. The Endocrine Society also notes
that PTH levels begin to plateau in adults with a 25(OH)D concentration between
30-40ng/mL, this normalization of PTH indirectly implies that this 25(OH)D
concentration can be used to define insufficiency (25(OH)D<30ng/mL). Together
these studies suggest that 25(OH)D≥30ng/mL should be considered as sufficient,
but a 25(OH)D>40ng/mL ensures that sufficient status is met and may be
beneficial for muscle health.
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The effects of maintaining sufficient vitamin D status on physical function
in older adults is under investigation. A 5-year prospective study observed that
higher vitamin D levels with adequate physical activity may prevent functional
decline [38]. This study followed 615 community-dwelling adults over the age of
50 and observed that higher vitamin D and physical activity levels were
associated with decreased gains in body fat and decreased decline of muscle
mass. Likewise, during exercise, higher vitamin D levels were associated with
increased fat oxidation, further contributing to overall improved muscle health
[62, 63]. Sinha et al. [63] examined the effects of vitamin D supplementation
(20,000IU of vitamin D3 every other day for 10-12wks) on skeletal mitochondrial
oxidative function in severely deficient adults (n=12, 25(OH)D<6ng/mL, age: 1850) that presented to a primary care facility with fatigue or muscle cramps. The
authors’ observed an improvement in mitochondrial oxidative function as serum
25(OH)D was negatively associated with phosphocreatine recovery half-time (T1/2
PCR). Magnetic resonance spectroscopy was used to quantify the T1/2 PCR, the
time for PCR to decrease below 50%. PCR is typically used as an index to
measure mitochondrial oxidative capacity. PC is readily and rapidly broken down
by creatine kinase into creatine and phosphate. The phosphate is then donated
to adenosine diphosphate (ADP) to form adenosine triphosphate (ATP) which is
used to fuel the cell for short intense activity (<10s). The resynthesis of PC postexercise is inversely proportional to the rate of oxygen consumption, suggesting
that PC recovery could be used as an index of oxidative ATP production and a
measure of mitochondrial function [64]. Further higher 25(OH)D concentrations
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were positively associated with improvements in fatigue and myopathy
symptoms. These studies suggest that there may be synergistic interaction in
which vitamin D and exercise combined are multiplicative and not simply additive
[53] and provide a protective effect for muscle decline. In combination, these
findings may suggest that vitamin D supplementation, which increases and
maintains adequate 25(OH)D concentrations, may result in muscle function
improvements for those who have a baseline vitamin D deficiency.
Over the past several years researchers have been investigating the direct
and indirect effects vitamin D has on muscle tissue. Vitamin D can act on the
skeletal muscle through genomic and non-genomic pathways involved in cellular
metabolism and function. The genomic pathway is slow-acting; whereas the nongenomic pathway is fast-acting (seconds to minutes). Vitamin D receptors (VDR)
and CYP27B1 (gene which codes for the protein 1 alpha-OHase) are both
expressed in adult muscle cells allowing for circulating and locally converted
calcitriol to act on the muscle [65, 66]. VDR is a ligand-dependent transcription
factor. Once VDR is bound by calcitriol it can translocate to the nucleus and play
a role in the genomic pathway. In the nucleus, VDR forms a heterodimer with the
RXR and binds to the vitamin D response elements in skeletal muscle’s DNA,
thereby activating gene transcription and expression [66-68]. It is thought that
binding of calcitriol to non-genomic VDR promotes the phosphorylation of
intracellular proteins and formation of second messengers, which upregulate
intracellular calcium and increase pathways involved in muscle protein synthesis
[66-68]. Vitamin D regulates muscle contractions through controlling calcium

22

handling within the muscle cell [2]. During a muscle contraction nerve stimulation
cause a depolarization of the sarcolemma, which leads to calcium release from
the sarcoplasmic reticulum. Calcitriol can act on calcium binding proteins such as
calmodulin, located on the sarcolemma and sarcoplasmic reticulum, to regulate
calcium flux [66].
Unfortunately, these genomic and non-genomic pathways may be less
efficient with aging as skeletal muscle VDR expression was negatively
associated with age in muscle tissue of female orthopedic patients [69]. These
findings were independent of biopsy location or 25(OH)D concentrations. There
was no relationship reported between VDR expression and vitamin D status,
which may be due to the small sample size (n=20) and primarily low 25(OH)D
concentrations (<20ng/ml). This cross-sectional trial was not able to address
whether VDR expression could be increased by vitamin D supplementation in
vitamin D deficient individuals. As vitamin D and VDR play an important role in
muscle strength and performance observational and randomized controlled trials
have been completed to understand the mechanistic role of vitamin D and VDR
in muscle health [68].
One study observed that treatment with calcitriol in human myoblasts
increased VDR gene expression in a dose-dependent manner [70]. Vitamin D
supplementation increased VDR concentration and cross-sectional muscle fiber
size in human cells [65, 71]. In C2C12 mice myoblasts, similar results were seen
as treatment with calcitriol increased protein synthesis [66]. Furthermore, as part
of a randomized double-blind placebo-controlled trial, vitamin D supplementation
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over 4-months had a persistent 20% increase in VDR expression and muscle
fiber size in women 65 years of age or older [65, 66].
1.2 Musculoskeletal Lipid Droplets Characteristics
Musculoskeletal lipid droplets can be classified as intramyocellular (IMCL)
or extramyocellular (EMCL) lipids. IMCL is fat that is stored within the muscle
cell, typically in close proximity to the mitochondria [72, 73]. Conversely,
extramyocellular lipid is adipose tissue accumulation outside of the muscle cell.
This adipose tissue accumulation infiltrates the interstitial layers of the muscle
[74].
1.2.1 Intramyocellular Lipid Characteristics
Skeletal muscle lipid depots serve as a dynamic energy substrate. There
exists a high degree of IMCL heterogeneity including size, cellular location, and
type of proteins located on the lipid droplet phospholipid monolayer [73]. IMCL
can range between 0.3um and 1.5um in diameter, with larger sized and greater
amount of IMCL droplets in Type I (oxidative slow twitch) compared with Type II
(fast twitch) muscle fibers [75]. IMCL is located in-between a series of
sarcomeres, known as myofibrils, and is typically located adjacent to the
mitochondria [72]. Although lipid droplet motion during muscle contraction
remains somewhat uncharacterized, researchers assume that due to the
restrictions within the cell very limited movement occurs [73].
Primarily, IMCL is comprised of triacylglycerol (TAG) and diacylglycerol
(DAG) and multiple enzymes play a role in lipid depot formation.
Monoacylglycerol (MAG) can be acylated to form DAG with subsequent acylation
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to form TAG. Both monoacylglycerol acyltransferase (MGAT) and DAG-Oacyltransferase (DGAT) play a role in the MAG-DAG-TAG pathway. Furthermore,
two isoforms of DGAT enzymes are located within the muscle (DGAT1 and
DGAT2). DGAT1 and DGAT2 are located in the endoplasmic reticulum, but
DGAT2 is also located on the mitochondrial membrane and may also be located
on the lipid droplet monolayer. DGAT2 is thought to be involved in the formation
of TAG [73]. These lipid droplets are synthesized in the endoplasmic reticulum,
however the precise mechanism by which the lipid droplets are formed is still
under investigation.
Coat proteins are embedded throughout the phospholipid monolayer [73,
76]. Five proteins comprise the major protein family, perilipin (PLIN 1-5) [73, 76].
PLIN 2-5 are localized in the skeletal muscle [73, 76]. Specifically, PLIN2 aids in
lipid storage [73], PLIN3 plays a role in fat oxidation [73], and PLIN4 assists with
packaging of newly synthesized lipids [73, 76]. PLIN5 plays a role in the
interaction between the mitochondria and the lipid monolayer [73]. It has been
observed that endurance training increases PLIN5 expression [73, 76]. In
skeletal muscle, PLIN5 increases IMCL oxidative gene expression and thereby
may regulate substrate oxidation during exercise [73].
1.2.2 Factors Playing a Role in IMCL Turnover
Over the past decade, researchers have shown that IMCL depots are
extremely dynamic [72]. Increased IMCL content has been associated with aging,
insulin resistance, Type II diabetes, and obesity [72, 77]. Conversely, increased
IMCL content has also been observed in athletes with high endurance leading to
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the term “athletes paradox” [77]. In addition to an athletic population, obese
individuals after an aerobic exercise intervention experienced higher IMCL with
improved insulin sensitivity and greater oxidative capacity [74, 77, 78]. Due to the
paradoxical association of IMCL with insulin sensitivity and resistance, IMCL has
garnered prodigious interest from the scientific community.
Many factors play a role in IMCL accumulation, including age, adiposity,
diet, and exercise. Although aging has been associated with higher IMCL and
increased insulin resistance, this relationship is multifactorial. For example, de la
Maza et al. [79] compared healthy younger and older men and observed that a
greater IMCL content was associated with increased abdominal fat and insulin
resistance, independent of age. Choi et al. [80] compared normal weight and
obese older adults and observed that the obese group had a greater percentage
of Type I muscle fibers and a 2-fold greater number and total area of the lipid
droplets. Increased IMCL was associated with lower force, power, and slower
contractions in the muscle fibers. Conversely, acute (7 consecutive days) [74]
and chronic (16wk) [77] aerobic exercise interventions in older adults were
shown to improve insulin sensitivity, increase IMCL content [74, 77], and improve
oxidative capacity [77]. Our lab previously observed a positive relationship
between vitamin D status and IMCL in older adults, independent of physical
activity and BMI [59]. Also in C2C12 myotubes, calcitriol had a 1.5-2.0 fold
increase in expression of IMCL packaging proteins PLIN2 and PLIN3 [81]. In
combination, these data suggest that vitamin D and exercise may play a positive
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role in IMCL accrual, which can be oxidized during times of increased muscle
energy expenditure.
1.2.3 Extramyocellular Lipid Characteristic and Function
EMCL are visible adipocytes located within the muscle tissue and between
both muscle groups and muscle fibers [74, 82]. The physiological function of
EMCL still remains largely unreported and unknown [74, 83]. However, greater
EMCL accumulation has been observed with aging, greater adiposity, impaired
insulin sensitivity, and reduced physical function [58, 74, 84].
Hogrel et al. [85] observed that individuals’ 70-80 years of age had greater
EMCL compared with younger healthy individuals. Furthermore, it was observed
that EMCL was greater in older overweight men compared with older normal
weight women. Likewise, with greater BMI levels greater EMCL levels were also
observed [84]. Velan et al. [84] observed that overweight young adult males had
greater EMCL compared with normal weight males. Correspondingly, de la Maza
et al. [79] observed similar results in which greater central obesity was
associated with greater EMCL and insulin resistance. It is essential to note that
Haus et al. [74] observed a decrease in EMCL and insulin resistance after 7
consecutive days of aerobic training in obese, insulin resistant men.
Previous work has observed that lower 25(OH)D concentrations were
associated with greater EMCL in both the young and elderly. Tagliafico et al. [55]
observed that in the elderly vitamin D deficiency was associated with reduced
physical performance (balance and gait) and increased EMCL of the thigh.
Similarly, in young healthy women, vitamin D insufficiency was associated with
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increased EMCL [86]. Previously our lab found no relationship between EMCL,
25(OH)D, BMI or muscle strength and performance measures [59]. These results
may differ from aforementioned findings due differences in subject
characteristics, sample size, vitamin D status, and techniques used to quantify
EMCL.
1.3 Diet and Muscle Lipid
The interest in how dietary intake plays a role in preserving muscle health
is essential in maintaining muscle strength and function, which decreases with
aging [57]. As muscle lipid depots can affect muscle function, the role of diet on
IMCL and EMCL changes has garnered much interest. Initially it was thought that
through increased caloric intake, there was an increase in fatty acid uptake,
adding to the lipid overflow and leading to fat storage in the muscle [30]. With
concurrent low mitochondrial lipid oxidation and lipid turnover, muscle lipid was
implicated in increased insulin resistance [77]. However, the accretion of muscle
lipid (IMCL) congruent with greater mitochondrial oxidation and lipid turnover can
lead to improved insulin sensitivity. Recent data suggests that multiple lifestyle
factors can play a role in muscle lipid metabolism.
Dietary interventions may play a key role in reducing lipid overflow and
fatty acid processing in the skeletal muscle. Previous data suggests that there
are inter-individual gene expression changes in response to a high fat diet (HFD).
Studies have observed increased fat oxidation in lean subjects but not in obese
subjects. In order to further explore this relationship Kakehi et al., [87] examined
the effect of a HFD in healthy non-obese men. The 3-day HFD consisted of 60%
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fat (~45% saturated fatty acid (SFA), ~30% monounsaturated fatty acid (MUFA),
~25% polyunsaturated fatty acid (PUFA)), 20% carbohydrates, and 20% protein.
The authors examined high responders, those with large increases in IMCL,
versus, low responders, those with small increased in IMCL. The authors
observed that the high responders had upregulated gene expression related to
fatty acid oxidation. A short-term HFD may result in free fatty acid influx, which
exceeds the expenditure in the skeletal muscle leading to IMCL accumulation
and increased insulin resistance. The upregulated fatty acid oxidation gene
expression may suggest a compensatory mechanism to decrease lipid
accumulation.
Many studies suggest that the type of fat SFA, PUFA, or MUFA is an
important factor in lipid metabolism [88, 89]. In a single-blinded randomized
crossover trial, older insulin resistant men consumed either a high SFA, MUFA,
or PUFA diet [89]. The authors observed that compared with a high SFA diet, a
high PUFA diet was associated with reduced muscle uptake of fatty acids and an
increase in IMCL turnover. Furthermore, a higher MUFA and PUFA diet may
result in lower uptake of lipids into the skeletal muscle, as PUFA and MUFA rich
chylomicrons may be removed from the circulation via hepatic lipase instead of
lipoprotein lipase.
St-Onge et al. [90] examined the effects of 25d crossover controlled
feeding trial. Participants (19-65YO) consumed a low fat diet (14.2% from MUFA,
8.5% from SFA, and 5.2% from PUFA), a HFD (15.9% from MUFA, 11.4% from
SFA, and 5.8% from PUFA), and a high PUFA diet (15.3% from MUFA, 8.5%
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from SFA, and 9.7% from PUFA). The authors hypothesized that a higher PUFA
diet would result in lower IMCL accumulation compared with a HFD, as
unsaturated fatty acids are more readily oxidized compared with SFA. However,
they observed a decrease in IMCL after a low fat diet and an increase in IMCL in
both HFD interventions. The authors concluded that IMCL content is not
modulated by the dietary fat type but the total fat intake. Further, other
researchers have noted that the amount of IMCL is not as important as the
content and turnover of the IMCL [88, 89].
Animal models have suggested that the specific types of fatty acids exert
different influences on IMCL. Although, both unsaturated fatty acids and SFA
may lead to IMCL accretion, unsaturated fatty acids are preferentially oxidized
over SFA [88]. Overwhelmingly, cell and animal models have suggested that
SFA and trans-fats reduce insulin sensitivity, while PUFA improve insulin
sensitivity [88, 91]. Specifically, in cell studies, SFA such as palmitate, the most
prevalent free fatty acid in the plasma, alongside with stearate and arachidate
can be stored as IMCL and induce DAG and ceramide synthesis, inhibiting AKT
which results in downregulation of GLUT4. Together these actions lead to a
reduction in insulin sensitivity and overall decreases in glucose uptake.
Conversely, rodents fed a HFD enriched with n-3 PUFA, had a protective effect
against insulin resistance development. Specifically, eicosapentaenoic acid and
docosahexaenoic acid may increase lipid turnover by upregulating genes
involved in lipid oxidation [88]. Mice fed a HFD enriched with n-3 PUFAs for
10wks had a decrease in ceramide and long chain Acyl-CoAs implicated in
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increased insulin resistance [92]. The authors suggested that an n-3 PUFA diet
effects muscle lipid content by decreasing the bioactive lipid mediators, which
negatively influence insulin signaling. Although the authors did not report any
difference in mitochondrial oxidative capacity, they suggested that mitochondrial
membrane fluidity increases with an n-3 PUFA, while a high SFA diet can cause
rigidity in the membrane. Therefore, it is feasible that n-3 PUFAs would promote
an overall greater mitochondrial oxidation leading to greater lipid turnover.
To a lesser extent studies have examined the relationship between diet
and EMCL. Higher EMCL content was seen with obesity and has been
associated with insulin resistance. It remains unclear if EMCL is a marker of
insulin resistance or plays a role in contributing to insulin resistance. Haus et al.
[74], completed a combined intervention of a low-glycemic index diet and
exercise. The authors’ observed a decrease in EMCL, increase in IMCL, and
improved insulin sensitivity, but attributed these findings to the exercise regimen
and not the dietary changes. Studies have shown that a decrease in total caloric
intake and weight loss can lead to significant decreases in EMCL. However,
weight loss in older adults who may already be frail or have lower BMI may not
be a desirable option and instead physical activity should be considered [30].
1.4 Physical Activity and Muscle Lipid
Physical activity and exercise are related but differ in their definition.
Physical activity is defined as voluntary or involuntary body movement produced
by the muscle that results in energy expenditure, whereas exercise is defined as
a subset of physical activity that is structured, planned, and repetitive and used
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for the purpose to gain or maintain strength and aerobic capacity [93]. Exercise
has been implicated in both IMCL and EMCL. Multiple exercise interventions in
both young and older individuals have been conducted over the years to further
understand the effects of exercise on muscle lipid depots. One study recruited
both obese men and women, 60-75 years of age for a 16wk exercise intervention
[77]. The participants completed a 4-5d/wk, 45-minute session at a moderate
intensity (75% of heart rate maximum). Post-exercise, 21% increase in IMCL and
a decrease in both DAG and ceramides was observed. In addition, oxidative
capacity and capillary density improved. An 8wk randomized controlled trial
examined the effects on IMCL and skeletal muscle oxidative phosphorylation
[94]. Obese adolescence completed 20-minutes of stationary bicycling at 60-80%
heart rate reserved (difference between resting heart rate and maximum heart
rate) followed by 25-minutes of combined stretching and resistance training. The
authors observed an improvement in overall fitness and power, and consistent
with increased resting energy expenditure and lower respiratory quotient, an
increase in IMCL. These data suggest that there is a greater reliance on lipid
oxidation after an exercise intervention. Haus et al. [74] examined the effects of a
shorter, 7 consecutive day, exercise regimen (60 minutes/d, ~80-85% of heart
rate maximum) on insulin resistance, obese men. The authors observed a
decrease in EMCL and an increase in IMCL with improved insulin sensitivity
suggesting a potential change in lipid oxidation and mobilization to support
muscle demands.
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Unlike the aforementioned studies, Rouffet et al. [95] examined the
immediate muscle lipid changes in healthy, normal-weight to overweight males
with a combined short-term dietary intervention and exercise test. In this sample,
the authors observed that overall higher IMCL stores were associated with
greater VO2 max. A significant decrease in IMCL was observed after a 2-hour
exercise (treadmill walking at 50% VO2 max) leading to conclude that IMCL is
consumed and used during aerobic exercise. IMCL levels also increased after a
3d fat depletion-repletion diet (depletion equated to an intake of 26% fat, 58%
carbohydrate, and 16% protein for 2.5d followed by a repletion phase of 58% fat,
24% carbohydrate, and 18% protein intake) compared with a high fat diet (58%
fat, 24% carbohydrate, and 18% protein) alone. These studies provide evidence
for the dynamic storage and mobilization of IMCL with short and long-term
exercise interventions.
1.5 Scope of Dissertation
Aging is associated with changes in musculoskeletal health. Both muscle
strength and performance are reduced with age and muscle lipid metabolism is
altered. Vitamin D status, diet, and exercise all play a role in muscle lipid
metabolism and contribute to overall health and quality of life. Low vitamin D
status has been associated with increased EMCL and previously our lab
observed a positive linear relationship between 25(OH)D concentrations and
IMCL. However, there is a need to further examine how 25(OH)D and muscle
lipid depots related with physical function in a healthy older cohort. Furthermore,
studies have examined the effect of short-term dietary interventions on muscle
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lipid depot changes, but to date no research has been presented examining the
relationship of daily dietary habits and muscle lipid depots in older adults.
Preceding studies have examined the effect of structured exercise interventions
on muscle lipid; however, we will focus on how physical activity relates to muscle
lipid depots.
Specific Aim 1. To examine the relationship between 25(OH)D
concentrations and muscle lipid depots (IMCL and EMCL) in older adults.
Multiple factors contribute to this relationship including age, adiposity, and
physical activity. This chapter will discuss and compare the relationship between
vitamin D status and muscle lipid depots among older adults with different levels
of physical activity and adiposity.
Specific Aim 2. To elucidate the relationship between dietary intake and
physical activity on local muscle tissue hemodynamics and muscle lipid in older
adults. This chapter will discuss how dietary intake, specifically fat intake, relates
with muscle lipid depots. Further, structured exercise is known to improved global
and local tissue hemodynamics and this chapter will focus on the potential
relationship between physical activity levels and local muscle tissue
hemodynamics.
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Chapter 2: Methods and Materials
2.1 Novel Techniques
The skeletal muscle is involved in both mechanical and metabolic function
[96]. From a mechanical perspective, skeletal muscle is important for body
movement and posture control, which contribute to overall health and functional
independence. Metabolically, skeletal muscle plays an important role in glucose
homeostasis, fuel oxidation, and strongly influences basal metabolic rate [96].
Due to its important mechanical and metabolic function, various techniques have
been developed to quantify and assess skeletal muscle. Throughout history,
skeletal muscle has been difficult to quantify in vivo [97]. Traditionally skeletal
muscle was quantified through indirect measures such as urinary creatinine
excretion [98]. Recently, more sophisticated techniques have been used such as
Magnetic Resonance Imaging (MRI), computed tomography (CT), and Dualenergy X-ray absorptiometry (DXA) (Table 2.1).
These advanced techniques are especially important and are utilized to
observe and analyze muscle decline with aging. MRI provides a participant
friendly and non-invasive method to obtain high resolution MR images. Our lab
used MRI and MR spectroscopy (MRS) to examined both EMCL and IMCL in
adults 60 year of age or older. Further, our lab used non-invasive instrument that
combines Near-Infrared Spectroscopy and Diffuse Correlation Spectroscopy
(NIRS/DCS) to monitor blood flow and oxygen consumption during a dynamic
foot plantar flexion exercise protocol. The combined techniques, MRI and
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NIRS/DCS, allow us to examine muscle lipid and hemodynamics, and use these
variables as an index to monitor local muscle tissue metabolism.
2.1.1 MRI and Muscle Lipid Depots
MRI is a non-invasive imaging instrument that can produce detailed 3dimensional images of the body including soft tissues, bones, and organs [99]. In
order to produce these images MR uses the magnetic properties of atoms. The
most abundant atom in the human body is hydrogen, which is commonly found in
water and fat. Atoms have 3 types of motion, which include electrons spinning on
their own axis, electrons orbiting the nucleus, and the nucleus spinning itself
about its own axis. In the absence of an applied magnetic field hydrogen nuclei
are randomly orientated, but when a strong static external magnetic field is
applied most hydrogens align with the magnetic field. The MR produces a strong
magnetic field which forces low-energy nuclei to align their axis of rotation
parallel to the static external magnetic field (B0), whereas high-energy nuclei
align anti-parallel to B0. Only a couple of hydrogens out of every million are not
aligned with the magnetic field; however due to the high number of hydrogen
atoms in the body these non-aligned hydrogens allow for a detailed image. With
a greater B0 (or higher Tesla) more hydrogens are aligned with the magnetic
field, which results in an improved signal, image resolution, and overall image
quality. It is important to note that each hydrogen nucleus spins on its own axis
and the B0 produces a secondary spin or wobble, termed precession, to the
hydrogen. Further, each nuclei has a gyromagnetic ratio, which is defined as the
ratio of the magnetic momentum of an atom compared to its angular momentum
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(the momentum an odd mass nuclei has in which the number of neutrons is
slightly more or less than that of protons resulting in a net spin or angular
momentum). These concepts are important as each nuclei has its own
gyromagnetic ratio and when exposed to the same field strength will precess at
different frequencies. For example hydrogen will precess at a different frequency
than carbon, which allows researchers to focus imaging on hydrogen and ignore
other atoms in the body.
In order to produce an MR image a short burst of energy in the form of
electromagnetic radiation known as radio frequency (RF) pulse must be added
towards the body part being imaged. When the RF pulse is applied, it allows for
excitation to occur by forcing the unmatched hydrogens to spin at a particular
frequency and direction, this is termed resonance. Both echo time (TE) and
repetition time (TR) are the basic RF pulse sequence parameters measured in
milliseconds (ms). TE is defined as the time from the application of the RF pulse
to the peak of the signal in the coil and TR is the time between each excitation
pulse. During the RF pulse, 3 gradient magnets, which are magnets inside the
MR scanner with lower magnetic field strength, are turned on and off to alter the
main magnetic field to create slices. Slices are area-specific images in which the
body part can be observed in any of the 3 axis: sagittal (X), coronal (Y), and
transverse (Z). When the RF pulse is off, hydrogens realign with the magnetic
field and the energy absorbed from the RF pulse is released and the signal is
received by the coil. Through a series of mathematical formulas, termed the
Fourier transform, the data is transformed into an image.
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The images, either T1- or T2-weighted, have a contrast gradient which
emphasizes contrast characteristics of anatomical structures and allows
researchers and physicians to examine different tissues. T1-weighted images are
characterized by bright fat and fatty bone marrow and dark water with short TE
and TR, whereas T2-weighted images are characterized by bright water and dark
fat using longer TE and TR. Due to the better signal-to-noise ratio during
scanning, T1-weighted images result in better anatomical delineation and are
typically used. T1-weighted images depend on the differences between fat and
water. If the TR is too long, both fat and water would return to B0 and the contrast
between the two would be reduced, resulting in an image with poor differentiation
of tissue. Thus, short-time TR parameters are set, which do not allow either
water or fat to fully return to B0 after a RF pulse is applied, resulting in a highcontrast resolution image. In addition, due to the different resonance frequency
between fat and water a chemical shift artifact occurs which produces white or
dark bands on either side of the anatomical object. In order to reduce this artifact
we use the same parameters to produce a fat saturated image. In this image we
suppress the signal from fat. Saturation of the fat signal allows for better contrastto-noise ratio and it is used to calibrate the non-fat suppressed image. Therefore,
the two MR images, non-fat saturated and fat saturated, are used to provide a
conventional MRI image of anatomical features.
Conventional MR imaging is used to assess structural images; however
new functional imaging techniques, such as MRS, are used to assess metabolic
changes in the body. MRS produces a spectrum that plots signal intensity versus
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frequency rather than an anatomical image. The signals at specific chemical
shifts (parts per million (ppm)) indicate different substrates in the body such as
lipids. A single voxel is a point in 3-dimensional space positioned within the area
of interest used to determine the relative amounts of each substrate. The
advantage of using spectroscopy is that it allows for relative amounts of various
metabolites, most notably lipids, to be measured.
A key advantage of administering a MR scan is that the MR does not emit
ionizing radiation unlike X-rays and CT scans. Likewise, MR imaging of the brain,
muscle, and ligaments/tendons results in higher quality images compared with
other imaging technologies. Further, the MRS technique allows for metabolites in
specific tissues to be assessed. Conversely, a major disadvantage of MR
imaging is the high cost of the equipment and the need for highly trained
personnel to operate the instrument. Due to the strong magnetic field that the MR
emits, ferromagnetic items can be attracted into the MR scanner and are a risk to
study personnel and the participant. Verbal screening and a hand-held metal
detector can be used to ensure the participant has removed all ferromagnetic
materials. Ferromagnetic implants and prosthetics are not compatible with the
MRI. For example, pacemakers are an absolute contraindication to MR imaging;
however, non-ferrous metallic implants may be imaged. Prior to scanning, details
about body implants or any foreign body objects are documented and assessed
to determine MR compatibility and safety. In addition, claustrophobic individuals
may feel uncomfortable in an enclosed MRI; however new open MRI options are
available although not all types of imaging are possible with an open MRI. During
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the scan the electrical current in the wires of the 3 gradient magnets are opposed
by the main magnetic field producing loud noise; therefore participants are
provided with earplugs. Finally, the main cause of distorted images is motion
artifact produced by the participant during scanning; therefore the individuals are
asked to remain still for a prolonged period of time.
In our study, MRI and MRS were used to measure EMCL and IMCL
content in the gastrocnemius (Figure 2.1). We chose to image the gastrocnemius
for its superficial anatomical location, which allowed us to combine MR
technology with NIRS/DCS used to assess hemodynamics in superficial tissues
[100]. With aging, a decline in muscle function and an increase in risk of fall were
observed [101, 102]. The gastrocnemius is key to gait stability in aging. Likewise,
age alterations in muscle lipid occur and often play a role in declining muscle
function. By examining EMCL and IMCL in the gastrocnemius we were able to
further the understanding of functional muscle decline with aging.
Prior to scanning, all participants completed a MRI safety screening form
(Appendix 1). Further, as dietary intake can influence muscle lipid content,
participants were asked to refrain from eating overnight prior to scanning.
Participants were positioned within a 3.0T TIM TRIO scanner (Siemens) in a feet
first supine orientation with their lower leg (left or right), in a fixed dorsiflexed
position, placed in a RF coil [59]. To minimize participant motion we taped the
participant’s foot in a dorsiflexed position to the coil. If repeat MRI scans were
completed, a small oil-filled capsule was taped to the calf muscle to ensure same
anatomical slices were acquired on the repeated visit. The capsule location was

40

recorded by measuring the distance from the most inferior point on the
participant’s heel to the middle portion of the capsule. In order to measure the
anterior-posterior location we measured from the tibia to the middle of the
capsule. At repeated scans the capsule was placed in the same location and
served as a reference for slice positioning during imaging. T1-weighted images,
non-fat and fat saturated, were completed and used to assess EMCL. 1H-MRS
was used to quantify IMCL. In order to obtain IMCL data a single voxel placed in
the gastrocnemius (TR/TE = 2,000/30 ms). In addition, an unsuppressed water
spectrum of the same parameters in the single voxel was obtained (TR/TE =
2,000/30 ms). To achieve optimal IMCL and EMCL peak separation 1) the voxel
was placed within the gastrocnemius avoiding EMCL and 2) automated gradient
and manual adjustments of the gradient were performed. Total imaging time was
approximately 35 to 45 minutes.
Data was transferred from Siemen’s MR scanner to a Linux computer for
quantification of IMCL and EMCL. LCModel (version 6.3, Stephen Provencher,
Oakville, ON, Canada) was used to quantify IMCL using spectral fitting with water
scaling and eddy current correction. LCModel was employed to estimate lipid
peaks (1.5 ppm for EMCL CH2, 1.3 ppm for IMCL CH2, 1.1 ppm for EMCL CH3,
0.9 ppm for IMCL CH3) and creatine (2.8 and 3.0 ppm) (Figure 2.2). IMCL
methylene protons (1.3 ppm CH2), which were used for statistical analysis.
LCModel automatically scaled lipids and creatine to unsuppressed water peak
(4.7 ppm). Sets of T1-weighted images (TR/TE = 650/22 ms) for high-resolution
anatomy were used to assess EMCL. Gastrocnemius EMCL was quantified by
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manually drawn regions of interest (Figure 2.3) using a fat segmentation program
(FSL View, FMRIB Software Library, version 5.0) and percent fat was calculated
based on a mathematical formula published by Williams et al [103].
2.1.2 NIRS/DCS
Skeletal muscle typically constitutes 40% of total body mass and during
exercise skeletal muscle can use up to 85% of total cardiac output [104]. To
maintain overall muscle function and health, microvascular blood flow delivers
nutrients (e.g. oxygen) and removes by-products from the muscle [104, 105].
Hemodynamics explain forces that govern blood flow within blood vasculature
and are integral in understanding tissue function and its ability to respond and
adapt to stressors in both healthy and pathogenic muscle tissue [105]. Muscle
tissue function can be evaluated through measurements of blood flow (BF),
tissue oxygen consumption rate (VO2), and tissue oxygen saturation (StO2).
These measures provide an additional parameter to the process of disease
diagnosis and the ability to examine the efficacy of treatment.
Currently, many different modalities exist to measure aspects of
hemodynamics. MRI and Positron Emission Tomography (PET) scans are able
to continuously monitor microvasculature changes during dynamic protocols
[100, 104]. However, these instruments are relatively expensive and highly
sensitive to motion during dynamic exercises, which distorts signals and
produces motion artifacts. Another drawback is that these approaches require
cumbersome equipment that is not portable and may not be available in all
clinics. PET also requires the use of radioactive elements, which are harmful to
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patients [104]. Another invasive technique is blood draws from major vessels
through which blood gas levels can be determined. Measurements using this
method yield regional rather than local results including partial pressure of
oxygen, partial pressure of carbon dioxide, oxygen saturation, arterial pH, and
bicarbonate levels. To further the understanding of tissue function and its
adaptations to metabolic stress it is important to be able to measure
hemodynamics in a continuous, non-invasive, and inexpensive way.
Two novel and non-invasive optical technologies, NIRS and DCS, can be
used to study healthy and pathogenic tissues by quantifying relative changes in
the microvascular blood and measuring oxy- and deoxy-hemoglobin
concentrations [104]. Tissue hypoxia is commonly associated with various
disease states and can occur when arterial oxygen is low, blood flow is slow, or
local tissue metabolism is high. Numerous medical conditions including
cerebrovascular accidents (CVA), peripheral artery disease (PAD), and even
some cancers are associated with anomalies in hemodynamics. PAD is the
narrowing of peripheral arteries primarily in the lower limbs and does not
encompass the blood supply to the heart or brain. Vascular deficits are the
keystone in PAD patients and to some extent PAD patients have a poor
response to the metabolic demands of exercise. Following treadmill and pedal
exercise tests, an increase in relative blood flow (rBF) was observed in healthy
subjects, whereas PAD patients maintained relatively stable rBF [106]. Likewise,
the effect of fibromyalgia on the microvasculature was investigated by
NIRS/DCS. Fibromyalgia is characterized as the widespread musculoskeletal
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pain typically accompanied by reduced exercise tolerance, fatigue, sleep
deprivation, memory impairments, and mood disorders [107, 108]. Patients with
fibromyalgia had similar rBF with matched healthy controls; however lower
oxygen extraction was observed in the disease state [107]. These data highlight
the importance of monitoring multiple parameters to provide measures of local
muscle metabolism and the advantage of the novel and non-invasive nature of
NIRS/DCS.
NIRS oximetry is a reliable instrument used to determine oxy-hemoglobin
(HbO2), deoxy-hemoglobin (Hb), total hemoglobin concentration (THC), and
blood oxygen saturation (StO2) [100]. Advantages of NIRS include the ability to
assess tissue hemodynamics in a non-invasive continuous manner, monitor at
the bedside due to its easy portability, and penetrate tissue up to several
centimeters in depth. A well-known spectral window exists in NIRS (650-950nm),
in which tissue absorption is relatively low, allowing light to penetrate into
deep/thick tissue [105]. As photons pass through the tissue the photons scatter
when interacting with cell membranes, organelles, and nuclei or be absorbed
when interacting with HbO2 and Hb. At NIRS wavelength the scatter is greater
than the absorption and the photons will reflect back to the surface of the tissue
in which a detector can sense the photons. Three different techniques of NIRS
exist and differ in illumination type. The three paradigms are 1) continuous-wave,
2) frequency domain, and 3) time-domain. We use frequency domain in which
the inputted modulated light interacts with the tissue, such as the muscle, and the
change in amplitude and phase shift are detected. Measurements of these
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changes at multiple source-detectors allow for the quantification of absolute
values of deoxy-, oxy- and total hemoglobin concentrations [i.e. [Hb], [HbO2],
and [THC].
DCS is used to quantify changes in microvascular rBF in deep tissues.
Previously, only red blood cells in superficial tissue (<1mm) were able to be
monitored by laser Doppler. This technique utilized the single scattering theory,
which quantified the light fluctuations within a specified tissue area. However, in
deeper or ticker tissues the photons undergo multiple scattering that are
accounted for by the DCS. DCS uses near-infrared light to penetrate deep
tissues and measure light speckle fluctuations caused by the motion of red blood
cells [104]. Unlike other modalities for measuring BF in which a patient may be
exposed to ionizing radiation or contrast agents (eg. PET), DCS is non-invasive.
Most importantly it can be utilized for continuous monitoring during dynamic
exercise when a gating algorithm is applied.
Separately these two sophisticated tools can be used to monitor
oxygenation and BF in tissues. However, in combination, hybrid NIRS/DCS
instrument can be used to derive relative oxygen consumption (rVO2) employing
Fick’s principles [100]. Although Fick’s principles were initially developed for
measuring cardiac output, the principles can be applied to procure other
quantifications. Fick’s principles include knowing 1) how much of a substance is
consumed by the tissue per unit of time, 2) how much of the substance is in the
arterial blood supply to the tissue, and 3) how much of the substance is in the
venous blood leaving the tissue. Fick’s law states that the BF multiplied by the
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arteriovenous oxygen difference is equaled to rVO2. Using NIRS/DCS and
employing Fick’s laws, rVO2, relative oxygen extraction fraction (rOEF), and
relative BF (rBF) can be derived. Recently, the combination of the hybrid
NIRS/DCS instruments were used to continuously monitor hemodynamic
parameters during a handgrip exercise in forearm muscles [109]. These
methodologies were modified and applied to the gastrocnemius, a lower-limb
muscle, during a dynamic plantar flexion exercise [100].
In my study, NIRS/DCS was used to quantify muscle oxygen consumption
rate (VO2), BF, and tissue (muscle) oxygen saturation (StO2) in the
gastrocnemius during a plantar flexion exercise protocol (Appendix 2). A plantar
flexion exercise is the ankle movement of moving the foot down and pointing the
toes away from the body. A commercial NIRS oximeter (Imagent, ISS inc.) and a
custom built DCS flowmeter were used. The Baltimore Therapeutic Equipment
(BTE Primus, Hanover, MD) was used for the plantar flexion exercise.
Participants were seated at a 70° semi-recumbent position with the right calf
exposed for placement of the optical spectroscopy sensors. The right foot was
placed into the BTE plantar flexion attachment and secured with Velcro straps.
Participants completed a familiarization session followed by a testing session and
were given at least 48 hours of rest between these two sessions to avoid the
influence of muscle fatigue on tested measures. During familiarization and testing
sessions a warm-up was implemented to prime the body for increased oxygen
demand occurring with exercise and to reduce the risk of injury. Warm-up
consisted of at least 10 foot plantar flexion repetitions at 30º range of motion and
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a torque of 25% of bodyweight. Next, at least 5 maximal voluntary isometric
contractions (MVC) lasting 4-5 seconds were completed with a 30 second rest
period between each MVC [110]. Thirty-five percent of the highest MVC
recorded was used to set torque that the participant pushed against during a 75
foot plantar flexion repetition exercise [100]. To ensure consistent effort was
provided by the participants during MVC, additional MVC were performed if
coefficient of variation (CV) was greater than 10%.
After MVC was determined, the optical sensor was taped to the right
gastrocnemius. Right thigh occlusions were performed and used to calibrate the
NIRS/DCS device to obtain absolute baseline BF (ml/100ml/min) and absolute
baseline VO2 (ml/100ml/min). Occlusions consisted of three, 10 second venous
occlusions at 55 millimeter of mercury (mmHg) which blocked the return of blood
flow to the heart from the lower limb. One minute recovery periods between
venous occlusions were completed. Data from venous occlusions were used to
calibrate rBF (measured by DCS). Next, one, 3 minute arterial occlusion at 235
mmHg was completed and used to calibrate rVO2 to absolute VO2, with 5
minutes of recovery time (measured by NIRS). A 3 minute arterial occlusion
allowed for complete occlusion of blood flow into and out of the lower limb.
Recovery periods allowed tissue hemodynamics to return to baseline [100, 110].
Muscle BF, StO2, and VO2 rates were continuously measured 3 minutes
before the plantar flexion exercise to ensure hemodynamic stability, during the 75
plantar flexion repetitions (2.5-3 minutes), and for 15 minutes post-exercise to
monitor blood flow recovery. Participants were asked to complete the concentric
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plantar flexion contractions and the plantar flexion attachment automatically
completed the eccentric dorsiflexion contractions without participant assistance.
Verbal encouragement was used to ensure consistent effort throughout the 75
repetitions. NIRS/DCS instrument collected local muscle tissue parameters
(VO2, BF, and StO2) at the end of every eccentric phase plantar flexion (0.5s
measurements period) to minimize muscular motion artifacts due to muscle
contraction. These procedures were adapted from Henry et al. [100], in which
NIRS/DCS measures were translated from examining hemodynamic measures in
the forearm muscle during handgrip exercises to the gastrocnemius muscle
during plantar flexion exercise.
2.2 Clinical Assessments
Participants’ height, weight, blood pressure, and waist circumference were
measured. The study coordinator measured participants’ height using a wallmount stadiometer (DETECTO 3P, Webb City, MO or SECA 264). To ensure
precise measurements participants were directed to remove their shoes, hair
jewelry, hats or hairstyles such as buns or braids from the top of their heads and
stand on the stadiometer platform [111]. Participants were further instructed to
stand up straight against the backboard of the stadiometer and to the best of
their ability keep their head, shoulder blades, buttocks, and heels in contact with
the backboard. The head was aligned in the Frankfort horizontal plane, in which
the ear canal and the eye were parallel to the floor and perpendicular to the
backboard. Next, the participant was instructed to take a deep breath and hold
this position as the coordinator lowered the headpiece of stadiometer to rest
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firmly on top of the participant’s head compressing the hair. Measurements were
obtained one time and recorded in centimeters. Weight was determined using a
Tanita 800S scale (Tokyo, Japan). Participants were instructed to remove shoes
and any objects in pockets. The study coordinator calibrated the scale to zero
and instructed the participant to step and stand still on the scale platform. Once
the readout on the digital scale became stable the coordinator recorded the value
in kilograms. Body mass index (BMI) values were calculated using measured
height and weight values as weight (kilograms)/height (meters2). BMI categories
were defined as: underweight (BMI value <18.5), normal weight (BMI value 18.524.9), overweight (BMI value 25-29.9), obese class I (BMI value 30-34.9), and
obese class II (BMI value 35-39.9) and extremely or morbidly obese (BMI value
≥40) [111, 112].
The study coordinator obtained blood pressure using a standard
(16centimeters (cm) width; 30cm length) or large adult (16cm width; 36cm length)
automatic blood pressure cuff. The participant was in a seated position with the
arm uncovered and the cuff placed on either the right or left arm approximately
2cm above the bend in the elbow [113]. The center of the inflatable portion of the
cuff was positioned over the brachial artery and the cuff was at heart level.
Participants were asked to place both feet flat on the floor and sit silently during
blood pressure measures. The study coordinator recorded the systolic and
diastolic values (mmHg).
Waist circumference (Gulick II Measuring Tape, Wisconsin, USA) was
measured by the study coordinator three successive times and the results were
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averaged. The inelastic, flexible tape measurer was placed on bare skin surface
without compressing the subcutaneous adipose tissue [114]. The smallest
circumference above the umbilicus and below the xiphoid process was used for
tape measure placement. The participants were asked to stand still, cross their
arms and place their hands on the opposite shoulders. The participants were
instructed to breathe normally and measurements were recorded at the end of a
normal exhalation [111, 114].
Registered nurses, licensed practical nurses and phlebotomists at the
Center for Clinical and Translation Sciences at the University of Kentucky
completed all blood draws [115]. Prior to blood draw, participant’s identification,
name and date of birth, were verified and the participant sat in a comfortable
position. The tourniquet was placed approximately 3-5 inches above the
venipuncture site on either the left or right arm. A winged infusion set, butterfly
clip, was used on either the antecubital area or if arm vein attempt was not
successful on the dorsal surface of the wrist. If the individual collecting the
specimen did not obtain an appropriate specimen after two attempts the
assistance of another staff member was requested. A gold top tube (3.5ml) was
used to collect serum and 25(OH)D, the sum of 25(OH)D2 and 25(OH)D3, was
analyzed by liquid chromatography/tandem mass spectrometry with a CV of
10%. The University Biospecimens Core of the Center Clinical and Translational
Science completed all blood analysis.
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2.3 Medical History Questionnaire
A non-validated medical history questionnaire was administered
(Appendix 3). The questionnaire inquired about prescription drugs and any overthe-counter medications including dietary supplements. In addition, current and
past smoking status, allergies, chronic illnesses or viruses, past surgeries, and
family history of pulmonary, metabolic disease, stroke or sudden death were
documented. The questionnaire also inquired about any other reasons why the
participant should not take part in physical activity (eg. neuromuscular or
metabolic disorders, breathing issues, asthma, or emphysema). Finally,
participants were asked if they were currently seeing their healthcare provider for
any reason and if applicable to provide further explanation.
2.4 Socioeconomic Status Questionnaire
A series of questions that inquired about participant’s socioeconomic
status (SES) was administered [116]. The SES questionnaire inquired about
educational attainment, household size, annual household income, and current
and past employment status. This information was collected in order to examine
the extent to which differences in SES may play a role in vitamin D status,
physical activity levels, and dietary intake.
2.5 Diet Assessment
Participants were asked to continue regular dietary intake throughout the
study. Personnel (interviewer) trained in the use of nutrition research software
conducted an interview by phone to complete a 24-hour dietary recalls on two to
three non-consecutive days. The recalls were obtained on at least one weekend
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and one weekday to account for variance in caloric intake based on the day of
the week [117]. The Nutrition Data System for Research (NDS-R, Version 2015,
University of Minnesota, Minneapolis, MN) was used to obtain and analyze
dietary intake [118].
The NDS-R system employs the multiple-pass method to ensure the
validity and reliability of the dietary data [117, 119]. The multiple-pass method
refers to a standardized five-step procedure designed by the United States
Department of Agriculture to minimize the occurrence of misreporting and various
forms of bias by confirming food items and portion sizes throughout the interview
[117, 119, 120]. The first pass involved obtaining a list of all foods and beverages
consumed in the previous 24 hours. During the second pass the list was
reviewed with the participant for completeness and correctness. Third, the
interviewer collected all details about each reported food and beverage item,
including method of preparation and amount consumed. Fourth, the interviewer
probed for commonly forgotten foods, such as snacks or beverages consumed
throughout the day. Lastly, the detailed information was read back to the
participant and reviewed for completeness and correctness [121]. In addition, the
participant was asked if the amount of food they consumed in the previous 24
hours was equal to, greater than, or less than the amount typically consumed.
Likewise, information on any dietary supplements consumed (type and dose)
was recorded.
The NDS-R database includes over 18,000 foods and 8,000 brand name
products [121]. Further this system provides the ability to account for differences
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in food preparation methods, which allows for a complete and thorough dietary
recall. Values for nutrients and nutrient ratios were generated by the database
and used to assess the relationship between dietary intake and muscle lipid.
2.6 Physical Activity Assessments
Participants wore an ActiGraph GT3X monitoring device (Actigraph,
Pensacola, FL), a reliable and valid tool to measure physical activity in older
adults [122]. Participants were instructed to wear the device on a belt over their
non-dominant hip for seven consecutive days. Participants were instructed to
remove the accelerometer before bathing or participating in any other water
based activity and before sleeping.
The device is lightweight (27g), small (3.8x3.7x1.8cm) with a rechargeable
battery [123]. The device is tri-axial and able to detect and collect data on 3 axis:
horizontal right to left (X), vertical (Y), and horizontal front to back (Z). Data is
collected using a time sampling interval (epoch) of 10 seconds, which Actigraph
software outputs as counts. These counts were linearly related to the intensity of
the participant’s physical activity levels and were derived from vector magnitude
(VM) defined as √X2+Y2+Z2. We based our definition of sedentary, moderate,
and vigorous physical activity in older adults on previously valid and reliable VM
cut-off points developed by Santos-Lozano et al [123]. Sedentary or inactivity,
such as sitting, ironing, laundry, washing dishes, and cooking, was identified as a
VM cut point of <2751, which amount to <3 metabolic equivalents (METs). MET
is defined as the amount of oxygen consumed during a specific activity. One
MET is defined as the amount of oxygen consumed while sitting quietly in a chair
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and is equivalent to 3.5ml/kg/min [124]. Moderate activity (3-6 METs) was
defined as 2751 to 9359 (VM) which included activities such as window washing,
vacuuming, gardening, yard work, or recreational activities. Activities such as
biking or running, with a VM >9359, were considered vigorous (>6METs).
The ActiLife 6 software was used to analyze all data (version 6.11.9). Data
from the ActiGraph provided detailed information regarding daily physical activity
and length of time (minutes) that each participant spent at various levels of
physical intensity. Meeting the Center for Disease Control guidelines on physical
activity was defined as engaging in an average of >30minutes/weekday of
moderate aerobic activity [125].
A Physical Activity Scale for the Elderly (PASE) questionnaire was
administered to obtain a self-reported measurement of occupational, household,
and leisure activities during the previous 7 days. Activity items required
participants to report the number of days per week the activity was performed
followed by the number of hours per day. Study personnel scored the 12-item
questionnaire based on instructions published by The New England Research
Institutes in which greater reported activity levels were associated with higher
scores [126]. Total score were used for statistical analysis and typically ranged
from 0 to 400. Validity and reliability of the PASE questionnaire has been
previously established in individuals older than 65 years of age (Table 2.2) [126,
127].
Participants also completed the Physical Activity Readiness Questionnaire
(Appendix 4) [128], American Heart Association/American College of Sports
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Medicine Facility Preparticipation Screening Questionnaire (Appendix 5) [129],
and an un-validated physical activity habits survey (Appendix 6) inquiring about
the frequency, duration, and type of physical activity.
2.7 Physical Functional Assessment
The Four Square Step Test (FSST) was established as a reliable and valid
tool used to test dynamic balance and mobility in adults over 65 years of age
[130]. The test is quick to administer and requires no special equipment. It is both
a sensitive and specific measure that can be used to discern between older
adults that have experienced falls compared with non-fallers.
The FSST required participants to move in different directions and step
over a one-inch obstacle on the floor (Figure 2.4). An exercise physiologist
instructed participants to step over a plastic pipe lying flat on the ground for each
of the following directions: 1) forward, 2) sidestep to the right, 3) backwards, and
4) sidestep to the left. This was repeated in the opposite direction and the total
time to complete the task was recorded. Participants completed one practice trial
to become familiarized with the test followed by three test trials. Only the fastest
test trial was used for data analysis. A cut-off score of greater than 15 seconds
for completion was used to indicate a greater risk for multiple falls for adults
greater than 65 years of age [130].
2.8 Graded Exercise Test (GXT)
A multi-stage GXT was used for the assessment of respiratory and
circulatory function using Vmax Encore (Carefusion, Yorba Linda, CA). This test
was commonly used at University of Kentucky for sedentary or aged individuals
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and included a progressive 2-minute workload stages (Table 2.3, Appendix 7). At
the final minute of each stage, heart rate, blood pressure, and rate of perceived
exertion (RPE) were recorded. During the test, breath-by-breath measurements
of oxygen consumption and continuous 12-lead electrocardiogram (EKG) were
monitored.
VO2max is defined as the maximal rate of oxygen uptake during maximal
exercise [131]. When the oxygen uptake plateaus and does not increase by more
than 150ml/min with further increases in workload, VO2max is reached.
However, many individuals do not reach the oxygen uptake plateau and
additional criteria for VO2max may be used to indicate if a true VO2max has
been reached. Additional criteria were the following: failure of heart rate to
increase with increases in exercise intensity, venous lactate concentrations ≥8
mmol/L, respiratory exchange ratio ≥1.1, and RPE≥17 on the original Borg scale
(6-20). VO2 peak is the greatest rate of oxygen consumption measured during
the test regardless if a plateau is reached. VO2 peak can be higher, lower, or
equal to VO2max. Many individuals do not reach their true VO2max as oxygen
uptake does not plateau; however VO2 peak attained during a maximum effort
treadmill test, such as our GXT, is a valid index of cardiorespiratory fitness [131].
Normative data for VO2max in older adults are depicted in Table 2.4 [131].
Participants were closely monitored and verbal encouragement was provided
throughout the test. Upon completion of the GXT, recovery (cool-down) exercise
was performed for at least 5 minutes or until heart rate was <100 beats per
minute. Test termination was based on volitional fatigue or the presence of any
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absolute or relative contraindications according to the American College of
Sports Medicine Guidelines [114]. A trained exercise physiologist performed all
testing and a physician reviewed all medical history prior to testing and post-GXT
results for contraindications to study participation.
2.9 Aerobic Training
For 7 consecutive days, participants randomized to an aerobic training
protocol performed up to 45 minutes of treadmill exercise (Landice Cardio,
Randolph, NJ). Training protocol was based on a previous protocol implemented
in a similar population [74]. The exercise consisted of treadmill walking at a
progressive intensity of about 60-65% of their maximum heart rate (maximum
heart rate = 220 - age). During each exercise session participants had their blood
pressure measured before and after the exercise. Participants wore a heart rate
monitor to monitor their individualized target heart rate and maintain intensity. As
an added safety measure participants were allowed to significantly reduce their
training intensity to a slow walk for 5 minutes at any time they requested. Each
training session incorporated a brief standardized warm-up and cool down. The
study coordinator supervised every session and compliance with all training
sessions was carefully documented (Appendix 8).
2.10 Body Composition
Body composition changes occur with aging often without body weight or
BMI changes [132]. Generally, fat mass increase and lean mass and bone
mineral density (BMD) decrease are observed with aging. Further, the changes
in fat mass distribution occur during aging with a greater accumulation of fat in
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the abdominal region. Numerous body composition instruments and techniques
can be used to measure body composition; however, DXA and CT imaging
provide a sophisticated approach to quantify fat and lean mass [97]. Traditionally,
DXA scans were clinically used to monitor osteopenia/osteoporosis, but both
DXA and CT scans can also be used to estimate fat and lean tissue content in
total body or body segments. Further, CT scans can provide a cross-sectional
image of visceral fat and fat infiltration in lean tissue.
2.10.1 DXA Imaging
The DXA scan is a highly preferable method used in research due to its
ability to estimate bone mineral density, fat and lean soft tissue content in an
expedient scanning time with minimal cooperation from the participant [131]. The
imaging is dependent on the attenuation of the X-ray through various tissues that
differ in their densities and chemical composition. DXA body composition
assumptions include that 1) a constant attenuation of pure fat and bone-free lean
tissue was maintained, 2) measurements were not affected by anteroposterior
thickness, 3) the composition of each body region was equally represented in the
calculation of total body values, and 4) that one tissue was analyzed at a time.
A DXA scan was performed at the CCTS by a study personnel trained in
this procedure. A total body DXA scan was performed using a Lunar Prodigy (GE
Lunar Inc., Madison, WI) bone densitometer. Participants were instructed to
remove all objects such as jewelry or eyeglasses and wear a hospital gown or
light-weight clothing (containing no metal) during the scanning procedure. The
scans took approximately 8-10 minutes. Scans were analyzed using the GE
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Lunar software (version 10.0). Total body, regional fat and fat-free mass (FFM;
kg), mineral-free lean (MFL; kg) mass, and the appendicular skeletal muscle
index were assessed.
2.10.2 CT Imaging
A subsample of participants completed a CT scan and all scans were
administered and results analyzed by trained personnel. Single slice CT images
(Siemens) were used to quantify skeletal muscle and fat area of both right and
left thighs and abdominal visceral fat. A 100 milliampere (mA) tube current with a
3 second scanning time was chosen to produce quality images while limiting
exposure time of the radiation to the participant. CT image was composed of a
512x512 square matrix resulting in 262,144 pixels (512x512=262,144). The
attenuation coefficient is the measure of how easily the beam can go through the
material being imaged [133]. The pioneer of CT scanner, Godfrey Hounsfield,
created an attenuation scale to characterize the densities of air, fat, water, and
bone. In our study we used a modified version of the Hounsfield scale, in which
tissue area was quantified using the corresponding attenuation values: bone
≥200 Hounsfield Unit (HU); adipose tissue -190 to -30 HU; and skeletal muscle 0100 HU. With participants in a supine position, mid-thigh measures were
completed with a mark between the inguinal crease and the proximal border of
the patella. Total thigh fat was further subdivided into two compartments
including the fat above the fasica latae (subcutaneous thigh fat) and below the
fascia latae (deep thigh fat). In addition, the skeletal muscle was subdivided into
areas of low attenuation (0-34 HU) representing fat rich muscle, and high
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attenuation values (35-100 HU) representing muscle with normal fat content. The
software by the National Institutes of Health Image Processing and Analysis in
Java was used to analyze all data [134].
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Table 2.1 Advantages and disadvantages of MRI, DXA, and CT in vivo imaging

Method

Advantages

Disadvantages

MRI

-no ionizing radiation
-assessment of muscle
quality
-quantify muscle
compartments and fat depot
(IMCL & EMCL)
-widely available in clinical
settings

-expensive
-not widely available
-scanning and image analysis
requires trained personnel
-no gold standard in scan and
analysis protocols
-low dose exposure to ionizing
radiation
-no assessment of muscle
quality
-low dose exposure to ionizing
radiation
-lower reproducibility and
reliability compared with MRI
-no gold standard in scan and
analysis protocols

DXA

CT

-widely available in clinical
settings
-assessment of muscle
quality
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Table 2.1 Advantages and disadvantages of MRI, DXA, and CT in vivo imaging
The table outlines advantages and disadvantages of various imaging
technologies.
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Figure 2.1 T1-weight MRI axial image of the calf muscle
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Figure 2.1 T1-weight MRI axial of the calf muscle
Right calf T1-weighted transverse slice image. Major muscles and bones
were identified and labeled. To further allow for better peak separation between
EMCL (-CH2) and IMCL (-CH2), gastrocnemius voxel was placed to avoid
extramyocellular fat depots. Participant was a 66 year old Caucasian male with a
BMI of 26.8 kg/m2.
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Figure 2.2 1H-MRS spectrum of the gastrocnemius muscle to assess IMCL
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Figure 2.2 1 H-MRS spectrum of the gastrocnemius muscle to assess IMCL
1H-MRS spectrum of the human gastrocnemius muscle fitted using
LCModel (dark trace is the raw data; red trace is the fitted spectrum, and trace at
top of figure is the residual). Participant was a 73 year old Caucasian female with
a BMI of 22.2 kg/m2. IMCL (-CH3), methyl protons at 0.9 ppm; EMCL (-CH3),
methyl protons at 1.1 ppm; IMCL (-CH2), methylene protons at 1.3 ppm; EMCL (CH2), methylene protons at 1.5 ppm; creatine (-CH3) resonance at 3.0 ppm.

66

Figure 2.3 Highlighted regions of interests in the gastrocnemius to assess EMCL
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Figure 2.3 Highlighted regions of interests in the gastrocnemius to assess EMCL
Gastrocnemius muscles were manually segmented (highlighted in red)
from each axial image producing a transverse planar image (only 1 image of 15
are depicted). Participant was 64 year old Caucasian female with a BMI of
19.1kg/m2.
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Table 2.2 The New England Research Institutes’ PASE scores by age group and
sex
65-69 YO

70-75 YO

76-100 YO

Males

144.3±58.6

102.4±53.7

101.8±45.7

Females

112.7±64.2

89.1±55.2

62.3±50.7
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Table 2.2 The New England Research Institutes’ PASE scores by age group and
sex
The New England Research Institutes established the validity and
reliability of the PASE questionnaire [126]. Community-dwelling adults 65-100
year of age (n=222) were recruited. Higher PASE scores were significantly
correlated with greater performance measures and overall health status. The
mean±SD for age categories between sexes are presented.
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Figure 2.4 Four Square Step Test
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Figure 2.4 Four Square Step Test
The FSST is an inexpensive tool used to measure physical function in
older adults. The participant was instructed to stand in square 4 and step over a
1-inch obstacle to square one. The participant continued as fast and safely as
possible stepping into each square in the following sequence: 4, 1, 2, 3, 4, 5, 6,
7, and 8.
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Table 2.3 GXT
Stage

Time (min)

Speed (mph)

Gradient (%)

1
2
3
4
5
6
7
8
9
10

0-2
2-4
4-6
6-8
8-10
10-12
12-14
14-16
16-18
18-20

2.2
2.6
3.0
3.4
3.8
4.2
4.6
5.0
5.4
5.8

0
0
2
4
6
8
10
12
14
16
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Table 2.3 GXT
Table describe the duration, speed, and grade of each stage.
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Table 2.4 Cardiovascular fitness classifications: VO2 max (ml/kg/min)
Age (yr)

Poor

Fair

Good

Excellent

Superior

Females
60-69

≤25

26-28

29-31

32-36

37+

70-79

≤23

24-26

27-29

30-36

37+

Males
60-69

≤30

31-34

35-38

39-45

46+

70-79

≤27

28-30

31-35

36-41

42+
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Table 2.4 Cardiovascular fitness classifications: VO2 max (ml/kg/min)
Table describes the cardiorespiratory fitness classification for females and
males, 60 to 80 years of age.

76

Chapter 3: Specific Aim 1
3.1 Summary
A high prevalence of vitamin D deficiency and insufficiency has been
documented in older adults. It has been well established that vitamin D is linked
to bone health, but more recently, there is a growing interest regarding the
relationship between vitamin D and muscle health. With aging, muscle health
declines and changes in muscle lipid depots occur. PURPOSE: The objective of
this retrospective trial was to examine the relationship between 25-hydoxyvitamin
D (25(OH)D) concentrations, muscle lipid depots (intramyocellular lipid (IMCL)
and extramyocellular lipid (EMCL)), and physical function. We aimed to examine
if muscle lipid depots and 25(OH)D concentration were different between
individuals of varied BMI and physical activity levels. METHODS: Data from
adults 60 years of age or older who completed cross-sectional studies between
2012 and 2016 were combined. Blood was drawn to determine 25(OH)D
concentrations and at least one form of physical activity assessment was
completed (Actigraph accelerometry, Physical Activity Scale for the Elderly
(PASE) or physical activity questionnaire). Anthropometrics measures included
height, weight, waist circumference, dual-energy X-ray absorptiometry (DXA),
and computed tomography (CT) scans. Gastrocnemius IMCL and EMCL were
measured with magnetic resonance spectroscopy (MRS) and fat segmentation,
respectively. Pearson correlations and independent student t-test were
employed. RESULTS: Fifty-five participants took part in the 3 studies and a
subsample completed waist circumference (n=42) and the Four Square Step
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Test (FSST) (n=31). Eighteen of the 31 participants that completed the FSST
also completed DXA and CT scans. In the total sample, mean age and body
mass index (BMI) were 70.8±6YO and 25.9±4kg/m2, respectively. A significant
negative relationship was observed between 25(OH)D and EMCL (p=0.02). IMCL
was positively correlated with 25(OH)D concentrations (p=0.008). As BMI
increased, a general decrease in 25(OH)D concentrations and increase in IMCL
and EMCL was observed, but did not reach statistical significance. In females
only, greater 25(OH)D concentrations were significantly correlated with faster
FSST times (p=0.007). In addition, 25(OH)D concentrations and EMCL (p≤0.01)
were significant predictors of FSST when including BMI (p=0.558) and age
(p=0.163) in the model. CONCLUSIONS: Previous studies have observed
significant relationship between vitamin D status, BMI, and muscle lipid depots.
In accordance with previous literature, we found a relationship between vitamin D
status, muscle lipid, and physical function. Discovering that vitamin D status and
EMCL predict physical function independent of age and BMI in healthy older
adults is novel. Studies suggest a relationship exists between muscle lipid
depots, BMI categories, vitamin D status, and exercise; however further data is
needed to examine to what extent vitamin D repletion plays a role in muscle
health and function in vitamin D deficient older adults.
3.2 Introduction
In developed nations, vitamin D deficiency and insufficiency have become
a worldwide epidemic and a particular concern in older adults. It is difficult to
obtain sufficient vitamin D status through dietary intake alone; therefore, this
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epidemic can be primarily attributed to inadequate sun exposure and prolonged
time spent indoors without dietary supplementation [27]. Likewise, an increase in
adiposity has been related with decreased vitamin D status [41, 42]. In addition, a
reduction in the quantity of 7-dehydrocholesterol, the precursor of vitamin D, is
observed in aging skin, further contributing to lower vitamin D status in older
adults [28]. Studies reported that 20-100% of older adults were vitamin D
deficient [27, 50]. The wide variance in vitamin D deficiency is due to nonstandardized definitions of several factors including: vitamin D cut-off levels,
methodology for vitamin D concentration assessment, and age cut-offs used. The
National Institutes of Health set vitamin D deficiency (measured as 25(OH)D) as
<20ng/mL, which in healthy individuals is generally considered to be inadequate
for both bone health and overall health [26, 27].
Beyond bone health, research suggests that greater 25(OH)D
concentrations may be necessary to maintain muscle health [6, 24, 44, 45].
Lower 25(OH)D concentrations were associated with reduced muscle strength
and performance-based functional outcomes in the older adults [49, 50, 66].
Vitamin D supplementation trials have yielded mixed results primarily due to
varied study designs [49]. However, some low-dose vitamin D supplementation
trials, in deficient older adults, have shown improvements in muscle strength and
decreases in body sway [135, 136].
The mechanism in which vitamin D supplementation beneficially effects
skeletal muscle is still under investigation. Vitamin D can bind to the vitamin D
receptor (VDR) located on the muscle cell and act through both genomic and
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non-genomic pathways. These pathways contribute to the regulation of calcium
and muscle contractions, and an increase in quantity and size of Type II muscle
fibers [65, 66, 71]. Further, vitamin D has been associated with the quantity of
lipid found in muscle lipid depots, which play a role in muscle metabolism and
function [55, 59]. Muscle lipid depots are categorized as IMCL and EMCL. IMCL
is located within the muscle cell, typically in close proximity to the mitochondria
where the lipid can be readily oxidized during increased metabolic muscle
demands [72]. High IMCL content has been associated with greater insulin
resistance in obese, sedentary individuals. Paradoxically, in active individuals, an
increase in insulin sensitivity has been observed with high IMCL content [77].
EMCL is adipose tissue that has infiltrated the skeletal muscle and is located
between muscle fibers [82]. EMCL accumulation is thought to play a negative
role in muscle health, as reduction in physical function is observed with greater
EMCL content [74, 79, 84, 85].
Vitamin D deficiency has been linked to greater EMCL and reduced
muscle strength [50, 55, 66, 86]. In older adults, impaired gait and balance were
associated with lower vitamin D status and greater EMCL [55]. Recently, our lab
observed no relationship between vitamin D status and EMCL, but a positive
linear relationship was observed between vitamin D status and IMCL,
independent of reported physical activity and BMI [59]. Although muscle lipid was
not associated with the FSST, a measure of functional performance, we
observed a relationship between greater 25(OH)D concentrations and faster
FSST. These associations may be party explained at the cellular level with lipid
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depot alterations that occur with aging. In C2C12 myotubes, the addition of
calcitriol increased the expression and concentration of VDR, lipid packaging
proteins, and a protein (OXPAT) that promotes fatty acid utilization [66, 81].
Together these data may suggest that vitamin D is involved in the packaging and
mobilization of IMCL.
In addition to 25(OH)D concentrations, modifiable factors including
exercise and adiposity contribute to altering the quantity of muscle lipid depots. In
obese adolescents, an increase in IMCL, fitness, and power was observed after
an 8 week exercise intervention. IMCL increases were associated with increased
resting energy expenditure and a lower respiratory quotient suggesting greater
lipid oxidation [94]. In older sedentary adults, high IMCL content was observed
and associated with decreased force, power, and slower skeletal muscle
contractions [80]. Conversely, in older insulin resistant obese men who engaged
in 7 consecutive days of aerobic training, an increase in IMCL and decrease in
EMCL with concurrent improvements in insulin sensitivity was observed [74].
These studies show that exercise can lead to altered muscle lipid depots and
insulin sensitivity.
Adiposity is another modifiable factor that can plays a role in muscle lipid
depots changes. One study found that central obesity was associated with
greater IMCL and EMCL content, independent of age [79]. Velan et al. [84]
observed a proportional increase between weight categories (normal weight,
overweight, and obese) and both muscle lipid depots (IMCL and EMCL) in adults.
These studies suggest that adiposity is related with muscle lipid depot
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accumulation; however, the relationship between adiposity, vitamin D status,
muscle lipid content, and physical function outcomes have not fully been
investigated.
The objective of this retrospective trial was to examine the relationship
between vitamin D status, muscle lipid depots (IMCL and EMCL), and physical
function in adults 60 years of age or older. Further, we examined the influence of
adiposity on these relationships. Finally, we describe muscle lipid depots and
25(OH)D concentrations differences between individuals of varied BMI and
physical activity levels.
3.3 Methods
3.3.1 Participants
Individuals 60 years of age or older were recruited to participate. These
individuals resided in Southeastern United States (latitude 38°N). Exclusion
criteria included inability to walk up a flight of stairs without assistance, diabetes,
history of kidney disease, neurologic disorders, and myopathy. Additional
exclusion criteria included lower extremity injury or surgery and the initiation of a
resistance or aerobic training exercise regimen in 3 months prior to study
enrollment. Individuals with ferromagnetic implants or foreign bodies that were
magnetic resonance imaging (MRI) incompatible were not eligible to take part in
the study. The university institutional review board approved this study. Written
consent was obtained from all participants prior to study measures. Institutional
and governmental regulations concerning human participants in research were
followed including study data collection and management. Research Electronic
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Data Capture tool (REDCap) [137] was used for study data. REDCap is a secure,
web-based application designed to support data capture for research studies
hosted at the University of Kentucky.
3.3.2 Study Design
Participants completed visits between 2012-2016 (Table 3.1). All
participants completed anthropometric measures (height and weight). Blood was
drawn to assess vitamin D status (25(OH)D) and a MRI scan of the
gastrocnemius was completed to measure gastrocnemius muscle lipid depots
(IMCL and EMCL). Each participant completed a medical history questionnaire
and at least one form of physical activity assessment (accelerometry, PASE or
physical activity questionnaire). A subsample of participants completed waist
circumference measures, DXA and CT scans, GXT, and the FSST.
3.3.3 Statistical Analysis
Data collected over a 4 year period from 3 different studies was combined
and retrospectively analyzed. Power was retrospectively calculated using
Statistical Analysis System (version 9.4, Cary, NC) to examine the relationship
between 25(OH)D concentrations and IMCL. One participant, with a BMI of 35.2
(obese class II category), was excluded from study analyses due to poor IMCL
and EMCL peak separation post MRS analysis. Lack of peak separation resulted
in an overestimation of IMCL that was 3 standard deviations (SD) above the
mean. Based on a cross-sectional total sample of 55, a Fisher’s z-test was
employed to retrospectively calculate a power of 75.2%.
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Data analyses were completed using Statistical Package for Social
Sciences software (version 22, IBM, Armonk, NY). Descriptive statistics were
documented and Pearson correlations were employed to examine the
relationship between continuous variables. For mean comparisons of two
variables, the Levene’s test for equality of variance was completed following an
independent t-test. For mean comparisons between 2 or more variables a oneway ANOVA was employed. Linear regression was employed to investigate the
relationship between our variables of interest. A p≤0.05 was set as statistical
significance. Data were expressed as mean±SD.
3.4 Results
3.4.1 Participant Characteristics
Participants were between 60 and 84 years of age. All participants
completed the medical history questionnaire, blood draw, and height/weight
measures. Total sample characteristics and sample characteristics by sex group
are described in Table 3.2. Twenty-four participants’ were normal weight with a
BMI range from 18.7 to 24.9kg/m2 (mean = 22.5±2kg/m2). Twenty-three
participants were overweight with a BMI range from 25.4 to 29.9kg/m2 (mean =
27.5±1kg/m2). Eight participants were obese (class I) with a BMI range from 30 to
33.7kg/m2 (mean = 31.5±1kg/m2). A subsample of 42 participants completed
waist circumference measures (mean = 90.8±13cm). Waist circumference was
significantly different between females (n=18, 82.7±12cm) and males (n=24,
96.8±11cm) (p<0.001).
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3.4.2 Physical Activity and Fitness Characteristics
Thirty-one participants completed the physical activity questionnaire.
Participants reported their physical activity lifestyle demands as sedentary (n=1),
slightly active (n=5), active (n=19), or very active (n=6). Twenty-four participants
completed the GXT, PASE questionnaire, and wore an accelerometer. Due to
non-compliance of accelerometer wear, accelerometry data were only reported
for 23 participants. Peak VO2 measures obtained by GXT ranged from 15.5 to
51.4mL/kg/min (mean = 30±9.3mL/kg/min) (Table 3.3). Based on previously
established cardiovascular fitness categories [131], 5 males and 8 females were
classified as either poor or fair and 7 males and 4 females were classified as
either good, excellent, or superior. The PASE total score ranged from 57.2 to
431.1 with a mean of 148.7±87.2 (Table 3.4). Participants’ time spent in light,
moderate, and vigorous activity ranged from 666 to 940.8min/d, 23.3 to
108.3min/d, and 0 to 8.5min/d, respectively (Table 3.5). Nineteen of the 23
participants met the minimum 30min/d recommendation of moderate activity set
forth by the CDC [125]. Further, vector magnitude count (counts/minute/day) was
used as a continues variable to assess accelerometry data and ranged from
323.2 to 884.3 (mean = 569.5±135). VO2 measures positively correlated with
time spent in moderate activity (p=0.047) and negatively correlated with time
spent in light activity (p=0.009). PASE questionnaire scores were not correlated
with VO2 or accelerometry measures.
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3.4.3 Vitamin D Status
Nine individuals were vitamin D deficient (25(OH)D<20ng/mL) and 25
were vitamin D insufficient (25(OH)D 20-30ng/mL). Twenty individuals were
vitamin D sufficient (25(OH)D>30ng/mL) and 11 of 20 individuals had a
25(OH)D>40ng/mL. 25(OH)D concentrations for normal weight participants
ranged from 16 to 63ng/mL with a mean of 35±14ng/mL. For overweight
participants, 25(OH)D concentrations ranged from 17 to 50ng/mL with a mean of
29.7±8ng/mL. 25(OH)D concentrations for obese participants ranged from 15 to
68ng/mL with a mean of 27.5±18ng/mL. Although lower mean 25(OH)D
concentration were observed to be related with greater BMI categories, this
relationship was not significant (Figure 3.1). BMI and waist circumference were
correlated (p<0.001); however, 25(OH)D concentrations were negatively
correlated with waist circumference only (p=0.03) and not BMI (Figure 3.2).
Physical activity measured by PASE questionnaire and accelerometry did not
correlate with 25(OH)D concentrations. Further, 25(OH)D concentrations were
not different between reported physical activity levels (sedentary, slight active,
active or very active).
3.4.4 Muscle Lipid Depots Characteristics
Mean IMCL was 0.005±0.003au with a range of 0.001au to 0.017au. Mean
EMCL was 22.8±5.6% with a range of 8.9% to 39.8%. BMI was not correlated
with IMCL (p=0.11) or EMCL (p=0.06). Although not significant, both muscle lipid
depots, IMCL (Figure 3.3) and EMCL (Figure 3.4), increased with increases in
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BMI category. Waist circumference was not correlated with either muscle lipid
measure.
PASE score, GXT, and accelerometry measures did not correlate with
either muscle lipid measure. Participants that reported being active or very active
had lower EMCL (19.4±4%) compared with those who reported being sedentary
or slightly active (23.9±2%) (p=0.02). However, there were no significant
differences in IMCL content between individuals of varied activity levels.
3.4.5 Vitamin D Status, Muscle Lipid, and Physical Function
25(OH)D concentrations were positively correlated with IMCL (p=0.008)
(Figure 3.5). 25(OH)D concentrations were negatively correlated with EMCL
(p=0.02) (Figure 3.6). EMCL was also significantly higher in vitamin D deficient
individuals (25(OH)D<20ng/mL) (n=9; 26.8±6%) compared with individuals with a
25(OH)D>40ng/mL (n=11; 20.9±3%) (p=0.009).
Thirty-one participants completed the FSST with a mean time of 7.6±2s
and range from 4.2 to 12.8s. In the total sample, FSST did not correlate with
muscle lipid (Figure 3.7 (A)), 25(OH)D concentrations, BMI, or age. There were
no observed quintile differences between the slowest (mean = 10.1±1) and
fastest (mean = 5.5±1s) times to complete the FSST. There were significant
differences in FSST between males (n=15, mean 6.9±2s) and females (n=16,
mean 8.3±2s) (p=0.05).
In males no significant relationship was observed between 25(OH)D
concentrations, FSST (Figure 3.7 (B)), and muscle lipid. Conversely, females
with greater 25(OH)D concentrations had faster FSST times (p=0.007) (Figure
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3.7 (C)). In females, FSST positively correlated with BMI (p=0.012). Although no
correlation between FSST and muscle lipid depots were observed, 25(OH)D
concentrations (p=0.004) and EMCL (p=0.013) were significant predictors of
FSST when adjusting for BMI (p=0.558) and age (p=0.163) in the model (Table
3.6).
3.4.6 Muscle Lipid, Vitamin D Status, and Body Composition
IMCL and EMCL did not correlate with DXA or CT measures in the
subsample that completed body composition measures. Higher 25(OH)D
concentrations correlated negatively with total lean, leg, arms, trunk, android, and
gynoid (p≤0.005). 25(OH)D concentrations were not associated with any fat
measures.
3.5 Discussion
The purpose of this retrospective study was to examine the relationship
between 25(OH)D concentrations, muscle lipid depots, and physical function.
Our primary findings were that 25(OH)D concentrations were negatively
associated with EMCL and were not associated with IMCL when outliers, defined
as IMCL data points that was 1.5 times greater than the interquartile range, were
removed. 25(OH)D concentrations were related with physical function. In females
only, 25(OH)D concentrations and EMCL were the best predictors of faster
FSST. We assessed muscle lipid depots and 25(OH)D concentrations between
different BMI categories and physical activity levels. With higher BMI categories,
decreases in 25(OH)D concentrations and increases in muscle lipid depots were
observed, but statistical significance was not reached. There were no significant
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differences in muscle lipid depots with varied physical activity levels. Together
these data suggest that vitamin D status and muscle lipid depots play a role in
physical function and support previous study findings [55, 86].
In accordance with previous literature, we observed a negative linear
association between EMCL and 25(OH)D concentrations [55, 86]. Although the
metabolic role of EMCL remains largely unknown, higher EMCL has been
associated with decreased physical function and increased insulin resistance [58,
74]. Gilsanz et al. [86] observed a negative relationship between 25(OH)D
concentrations and fat infiltration in 90 postpubertal, healthy females (16-22YO).
Women with 25(OH)D≤29ng/mL had 24% greater muscle fat infiltration than
women with 25(OH)D≥30ng/mL. We observed that those with lower
(25(OH)D≤20ng /mL) has 6% greater EMCL compared with those with higher
(25(OH)D≥40ng/mL) vitamin D status. Although both our studies and Gilsanz et
al observed significant differences in EMCL content the magnitude of EMCL
varied. This variation of EMCL content between high and low vitamin D status
can be attributed to multiple factors including different subject characteristics,
sample size, and different techniques used to assess EMCL and physical
function. As no gold standard for quantifying EMCL exists, it can be difficult to
compare results across studies. We manually highlighted regions of interest and
quantified fat content in the gastrocnemius using a previously published formula
[103]; whereas others used CT [86] or MRI and subjectively graded images [55].
Tagliafico et al. [55] observed a similar relationship between 25(OH)D
concentrations and fat infiltration in 65 year old patients that were admitted to an
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internal medicine ward for non-oncological diseases. The authors reported that
individuals with lower 25(OH)D concentrations and greater fat infiltration had
impaired balance and gait. We did not observe a relationship between EMCL and
our physical function measure, FSST. However, in females higher, 25(OH)D
concentrations and lower EMCL content were significant predictors of FSST
performance times when adjusting for age and BMI. This was not observed in
male participants potential due to the wider distribution of 25(OH)D
concentrations in females compared with males. The majority (87%) of males
were vitamin D insufficient, whereas 25(OH)D concentrations were normally
distributed in females. These data indicate that there may be a relationship
between vitamin D, EMCL, and physical function as previous studies have noted.
The metabolic role of IMCL has been investigated for over two decades.
High IMCL content with physical inactivity has been associated with greater
insulin resistance [77]. Paradoxically, active individuals also exhibit high IMCL
content, but these relationships have been linked to greater insulin sensitivity.
Previously, our lab observed a positive linear relationship between 25(OH)D and
IMCL in healthy older adults independent of physical activity and BMI [59]. In this
retrospective analysis a significant relationship between 25(OH)D and IMCL was
observed; however this significant relationship may not be a true finding as three
data points drove this correlation to significance. Further, the discrepancy
between our current and past findings may be due to multiple other factors. With
a retrospective analysis a sample size of 55 provided us with a power of 75%,
thus we may be underpowered to detect significance between IMCL and
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25(OH)D concentrations. In addition, the majority of our sample (62%) had a
25(OH)D≤30ng/mL, while only 20% of our sample had a 25(OH)D>40ng/mL. The
narrow distribution in the 25(OH)D concentrations may have further contributed
to our lack of findings between vitamin D status and IMCL.
Multiple methods were used to assess physical activity and no participant
enrolled partook in an aerobic or resistance training regimen prior to start of the
study. Compared to physical activity, which encompasses routine daily activities,
exercise differs as it is defined as a planned, structured and repetitive task. [93].
Previous trials have observed that short and long term exercise influence muscle
lipid depots and positively affected muscle health [74, 94, 95]. In our study, we
aimed to examine the relationship between muscle lipid depots and physical
activity. We did not observe any relationship between muscle lipid depots and
physical activity measures (PASE questionnaire, accelerometry wear, or GXT).
However, as measured by the physical activity questionnaire, significantly lower
EMCL content was observed in individuals who reported being more active to
those individuals who reported being less active. Greater EMCL has been
associated with decreased gait and stability in older adults and engaging in an
exercise program has been shown to reduce EMCL [55, 74]. Our findings were
novel as the data suggests that increased physical activity and not just
engagement in an exercise regimen were related with lower EMCL content.
Unlike our physically active participants of which 83% met the CDC requirements
[125], less than 5% of general adult population engages in 30min/d of physical
activity [138]. Greater physical activity can delay or help maintain quality of life
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and provide an independent lifestyle with aging. Therefore, physical activity
should continue to be emphasized and encouraged in community and clinical
settings.
In addition to physical activity, lower adiposity can play an important role in
overall health. It is well established that even during periods of stable body
weight, lipid deposition changes occur with aging [90]. Central obesity increases
and fat infiltrates various tissues including the skeletal muscle. We did not detect
significant differences between BMI categories and muscle lipid depots, which
may be due to a small obese category sample size. de La Maza et al. [79]
observed increased muscle lipid depots (EMCL and IMCL) in both young (2755YO) and older (66-80YO) men. In the total sample, the authors observed that
overweight men had higher IMCL and EMCL compared with normal weight men.
Further, a significant positive relationship between muscle lipid depots and both
abdominal and trunk fat accumulation was observed. These data suggests that
independent of age, central obesity plays a major role in muscle lipid depots
accumulation. In our total sample, we did not observe a significant difference in
muscle lipid depots between BMI categories or central adiposity measures.
However, a general increase in muscle lipid depots was observed with increases
in BMI category. To decrease confounding variables we further examined these
results between females and males and observed that obese males had greater
IMCL content compared with normal weight males. This relationship was not
observed in females, which may be due the small sample size of only 3 females
classified as obese. Therefore, the discrepancy in significance can be attributed
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to the strict study selection. To avoid confounding variables de la Maza et al. [79]
recruited only young and older men with comparable body weights and physical
activity levels.
Velan et al. [84] observed that with greater BMI categories (normal weight,
overweight, and obese) younger men had increased IMCL and EMCL content.
Study selection was limited to healthy males not involved in any high-level
exercise training. With a small sample size of only eight individuals per group,
Velan et al. [84] detected significant differences in muscle lipid depots between
BMI categories. The discrepancies between Velan et al. [84] and our findings
could be that muscle lipid depots differences between BMI categories were more
difficult to detect due to the confounding variables of age and physical activity.
With age, changes in adiposity occur even during periods of weight stability [90]
and our study included a 24-year range between our youngest and oldest
participant. Further, in our study a wide distribution of physical activity was
documented. For example, 9 of 22 participants exceeding the CDC
recommendations of 30min/d [125] and engaged in more than 1 hour of
moderate physical activity. Despite the lack of significance, which in part can be
contributed to our heterogeneous sample, our results were in alignment with
previous literature as muscle lipid depots increases were observed with
increases in BMI categories.
Increases in adiposity have also been associated with decreased vitamin
D status. Two hypotheses have been attributed to the aforementioned
association, the fat sequestration hypothesis [42] in which the lipophilic nature of
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vitamin D promotes significant storage in adipose tissue and the volumetric
dilution hypothesis, [41] which suggest that the greater body size and fat mass
were associated with lower 25(OH)D concentrations. In our study we observed a
lower mean 25(OH)D concentration with greater BMI categories. Compared to
normal weight individuals, previous studies have observed a greater vitamin D
deficiency prevalence among obese individuals [43] while also showing small but
significant increase in 25(OH)D concentrations with weight loss [39]. We
observed a general mean decrease in 25(OH)D concentrations with increases in
BMI category and a significant negative relationship between waist
circumference and 25(OH)D concentrations. Waist circumference can be a more
sensitive measure of central adiposity than BMI, as with BMI normal weight,
overweight, and obese individuals can have comparable fat mass but fat may be
distributed in different parts of the body [139, 140]. We used more sophisticated
measures to assess adiposity (DXA and CT scans) and did not observe any
relationship with 25(OH)D concentrations and adiposity; however, these
measures were only completed in a subsample of participants (n=18) of which 9
were normal weight, 6 were overweight, and 3 were obese. Our data provides
further evidence for decreased 25(OH)D concentrations with greater central
adiposity.
There are limitations to this specific aim, primarily due to the nature of a
retrospective study design. Data was combined from 3 cross-sectional trials and
participants were recruited over a 4 year period and completed varied study
measures. Despite this, the inclusion and exclusion criteria was similar across
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each trial and primary variables of interest (muscle lipid depots and vitamin D
status) were measured using the same methodology. We observed that higher
25(OH)D concentrations and lower EMCL content were the best predictors of
physical performance. Further, a novel finding was that higher physical activity
levels were related with lower EMCL content. Future intervention trials are
necessary to determine if vitamin D supplementation in vitamin D deficient adults
can result in decrease in EMCL, effect IMCL, and improve overall physical
function.
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Table 3.1 Study trials and measures completed
Trials
Active Study Year
Study Measures
Muscle Lipid Depots
Blood Draw
Height/Weight
Waist Circumference
Physical Activity
Questionnaire
PASE Questionnaire
Accelerometery
GXT
DXA
CT
FSST

1
(n=13)
2012

2
(n=18)
2012-2013

3
(n=24)
2014-2016

x
x
x

x
x
x
x

x
x
x
x

x

x
x
x
x

x
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x
x
x

Table 3.1 Study trials and measures completed
A list of measurements obtained, sample sizes, and the year each crosssectional trial was completed.
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Table 3.2 Subject characteristics, mean±SD

Age (years)

Female
(n=28)
71±6

Male
(n=27)
70.6±6

Total
(n=55)
70.8±6

Height (cm)

163±7*

176.4±5*

169.6±9

Weight (kg)

66.3±10*

84±12*

75±14

Body Mass Index (kg/m2) 25±4*

27±3*

25.9±4

25(OH)D (ng/mL)

35.3±13*

28±11*

31.7±13

White

32

22

54

African American

0

1

1

Race (n)

*Significant differences between females and males (p<0.05)
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Table 3.3 VO2 peak measures between males and females across age
categories
Age (yr)

Females
(n=12)

Males
(n=12)

Total
(n=24)

25.7±8
34.8±10
30.8±10
(n=7)
(n=9)
(n=16)
23.8±7*
36±4*
28.4±9
70-79
(n=5)
(n=3)
(n=8)
*Significant differences between females and males (p<0.05)
60-69
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Table. 3.3 Peak VO2 measures between males and females across age
categories
Categories used were based on previous guidelines by Heyward et al.
[131] No differences in peak VO2 within sex categories and across age groups
was observed. Males and females in each age category were statistically
different between sexes with females reaching a lower peak VO2 levels.
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Table 3.4 PASE questionnaire by age category, mean±SD

Males

Females

60-64 YO
(n=8)
116.9±58
(n=5)

65-69 YO
(n=8)
124.1±32
(n=4)

70-75 YO
(n=6)
140.3±41
(n=3)

76-100 YO
(n=2)
(n=0)

Total
(n=24)
125.2±43
(n=12)

199.4±201
(n=3)

225.7±85
(n=4)

119.3±42
(n=3)

104.3±44
(n=2)

172.3±113
(n=12)

No statistical differences
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Table 3.4 PASE questionnaire by age category, mean±SD
Age categories were based on the New England Research Institutes’
PASE questionnaire. No statistical differences in PASE score between males
and females within or across age groups were observed.
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Table 3.5 Minutes per day spent in each activity level, mean±SD
Female
(n=11)

Male
(n=12)

Total
(n=23)

Light Activity
(<3METS)

837.6±62*

785.5±59*

810.4±65

Moderate Activity
(3-6 METS)

49.5±22

66.7±25

58.5±25

Vigorous Activity
(>6 METS)

0.2±0.2

0.9±2

0.6±2

*Significant differences between females and males (p<0.05)
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Table 3.5 Minutes per day spent in each activity level, mean±SD
Time (minutes) spent per day in light, moderate, and vigorous activity
levels. Females significantly spent more time in sedentary activity category
compared with males.
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Figure 3.1 25(OH)D concentrations across BMI categories
25(OH)D concentrations were reported across 3 BMI categories (normal
weight, overweight, and obese (A)) and across 2 BMI categories (normal weight
vs. overweight+obese (B)). Although a decrease in 25(OH)D from normal weight
to obese was observed mean 25(OH)D was not significantly different between
BMI categories.
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r=-0.334
n=42

Waist Circumference (cm)

140
120
100
80
60
40
20
0
0

10

20

30

40

25(OH)D (ng/mL)

107

50

60

70

Figure 3.2 The relationship between 25(OH)D and waist circumference
Waist circumference and 25(OH)D measures included males and females.
25(OH)D was negatively correlated with waist circumference.
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Figure 3.3 IMCL across BMI categories
IMCL contents were reported across 3 BMI categories (normal weight,
overweight, and obese (A)) and across 2 BMI categories (normal weight vs.
overweight+obese (B)). Although an increase in IMCL from normal weight to
obese was observed, the mean IMCL was not significantly different between BMI
categories.
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Figure 3.4 EMCL across BMI categories
EMCL contents were reported across 3 BMI categories (normal weight,
overweight, and obese (A)) and across 2 BMI categories (normal weight vs.
overweight+obese (B)). Although an increase in EMCL from normal weight to
obese was observed, mean EMCL was not significantly different between BMI
categories.
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Figure 3.5 Relationship between 25(OH)D and IMCL
A significant positive linear relationship was observed between 25(OH)D
and IMCL (A). IMCL data distribution depicted in a boxplot (B).

114

(A)
p=0.02
r=-0.314
n=55

45
40

EMCL (%)

35
30
25
20
15
10
5
0
0

20

40

60

25(OH)D (ng/mL)
(B)

115

80

Figure 3.6 Relationship between 25(OH)D and EMCL
A significant negative linear relationship was observed between 25(OH)D
and EMCL (A). The relationship remains significant despite the one data point
that was 1.5 times greater than the interquartile range (B).
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Figure 3.7 The relationship between 25(OH)D and FSST
The scatter plots indicate a negative relationship between greater
25(OH)D concentrations and improved physical function, as measured by the
faster FSST times, in the total sample (A), males (B), and females (C). A greater
25(OH)D concentration was significantly related with faster FSST times in
females only.
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Table 3.6 Variables that predict FSST

Predictor Variable

Estimate
(Standardized
Coefficients (Beta))

p-value

25(OH)D

-0.616

0.004

EMCL
BMI
Age

0.585
0.116
-0.271

0.013
0.558
0.163
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Table 3.6 Variables that predict FSST
BMI and age were not significant predictors of the FSST. Greater vitamin
D levels were a significant predictor of lower time to complete the FSST. Greater
EMCL content was a significant predictor of greater time to complete the FSST.
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Chapter 4: Specific Aim 2
4.1 Summary
Dietary fat intake, physical activity, and body mass index (BMI) may play a
role in age-associated changes in muscle lipid depots and local muscle tissue.
Higher intake of saturated fatty acids (SFA) was associated with greater
intramyocellular lipid (IMCL) content and lower lipid turnover in animal models.
Conversely, high intake of polyunsaturated fatty acids (PUFA) and
monounsaturated fatty acids (MUFA) were associated with increased lipid
turnover and improved metabolic health. In addition to diet, exercise plays an
important role in maintaining muscle health. However, to date human data
examining the relationship between modifiable lifestyle factors, diet and physical
activity, and muscle lipid depots are not well established. PURPOSE: The
purpose of this retrospective trial was to examine how dietary fat intake and
physical activity contribute to muscle lipid depots (IMCL and extramyocellular
lipid (EMCL)) and local muscle tissue hemodynamics in healthy, aged
individuals. METHODS: All participants were enrolled in a double-blinded
randomized-controlled trial (four group design: vitamin D repletion or placebo for
12wks with an additional week of aerobic training or no training). Twenty-four
hour dietary recalls were completed to assess dietary fat intake. Physical activity
questionnaire and graded exercise test (GXT) were completed at baseline (0wks)
and accelerometry wear was completed at baseline, midpoint (7wks), and
endpoint (13wks). Gastrocnemius IMCL and EMCL were measured with
magnetic resonance spectroscopy (MRS) and fat segmentation at baseline and
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endpoint near-infrared spectroscopy/diffuse correlation spectroscopy
(NIRS/DCS) measures were obtained before, during, and after a foot plantar
flexion exercise at 0 and 13wks. RESULTS: Twenty-four participants completed
all study measures. Mean age and BMI were 67.2±5YO and 25.3±4kg/m2,
respectively. EMCL was positively associated with SFA intake (p=0.026). EMCL
was greater in overweight and obese individuals compared with normal weight
individuals (p=0.006) and BMI was the only significant predictor of EMCL.
PUFA:SFA ratio was negatively related with IMCL at endpoint (p=0.029). With a
stepwise linear regression employed, the aerobic training protocol (p=0.014) and
the PUFA:SFA ratio (p=0.037) were the best predictors of IMCL when adjusting
for BMI, age, and time spent in moderate physical activity. Individuals that
reported greater physical activity exhibited lower relative blood flow (rBF) and
relative oxygen consumption rate (rVO2) during and after a plantar flexion
exercise. CONCLUSION: In concomitant with previous literature, these data
suggest that a higher unsaturated to SFA ratio intake may have a favorable effect
on muscle lipid depots and lipid turnover. Although preliminary in nature,
increased daily physical activity could relate with local muscle tissue
hemodynamics.
4.2 Introduction
Muscle composition alterations are observed with aging including
decreases in lean mass and increases in fat accumulation [30, 56, 77]. Inactivity
often increases with aging, further contributing to reduced muscle strength and
function [125]. In order to mitigate the deleterious muscle changes, it is
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imperative to understand the role of modifiable lifestyle factors on skeletal
muscle. Modifiable lifestyle factors can effect muscle lipid depots (IMCL and
EMCL) and local muscle tissue hemodynamics, which have been implicated in
muscle health [30, 100, 141]. In older adults, EMCL accumulation has been
associated with increased muscle weakness and decreased mobility [30, 55].
Conversely, high IMCL in combination with high lipid turnover has been
associated with insulin sensitivity [77, 141]. With aging, decreases in capillary
density were responsible for local tissue hemodynamics changes [142, 143].
Concurrently, lower erythrocyte perfusion is observed because of increased
thickness and impairments in the endothelial layer [142, 143]. Modifiable lifestyle
factors including exercise and dietary intake may positively alter muscle lipid
depots and skeletal muscle hemodynamics.
In both animals and humans, dietary interventions effect muscle lipid
depots, IMCL and EMCL. The type of fat (SFA or unsaturated fatty acids)
consumed may be an important factor in lipid metabolism. Kakehi et al. [87]
observed that a 3d high fat diet (HFD) intervention, primarily composed of SFA,
led to an increase in IMCL accumulation and impaired insulin sensitivity. St-Onge
et al. [90] observed higher IMCL content with 2 different HF diets (PUFA-rich and
SFA-rich) compared with a low fat diet; however, the authors noted that the
metabolic significance of a lower or higher IMCL content was unclear. In animal
models, a high PUFA diet intervention had a protective effect against the
development of insulin resistance [88]. A PUFA-rich diet was also associated
with greater IMCL turnover and lower muscle fatty acid uptake. It is thought that,
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due to the chemical structures, unsaturated fatty acids were more readily
oxidized compared with SFA [88, 89]. Greater lipid oxidation is associated with
increased lipid turnover, which may prevent the build-up of deleterious lipid
metabolites and promote insulin signal transduction leading to improved insulin
sensitivity [88]. Increased EMCL has been consistently associated with insulin
resistance and obesity [30, 144]. Overall decrease in caloric intake and weight
loss have been shown to decrease EMCL content [30]. After combined 7
consecutive day aerobic training and a low glycemic index dietary intervention,
Haus et al. [74] observed decreases in EMCL and increases in IMCL. These
muscle lipid depots changes were associated with improved insulin sensitivity
and were only attributed to the exercise regimen intervention. As weight loss is
accompanied by muscle mass loss, weight loss alone may not be a desirable
option for older adults. Therefore, increased physical activity levels and modified
dietary fat intake, rich in unsaturated fatty acids, may be one way to mitigate ageassociated muscle lipid depots accumulation.
Similar to dietary intake, physical activity is a modifiable lifestyle factor that
influences muscle function. Physical activity differs from exercise as it is
considered to as activities of daily living; whereas exercise is defined as a
structure, planned and repetitive activity [93]. Inactivity increases with age, with
33% of men and 50% of women 75 years of age or older, reporting no
engagement in physical activity [125]. Physical activity contributes to aerobic
fitness which decreases with aging. Aerobic fitness can be assessed with global
body VO2 measures [131]. Global oxygen consumption is the measure of total
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volume of oxygen consumed by the body per minute [145]; however, global
oxygen measures fail to monitor and assess the delivery of nutrients to the
tissues [104]. NIRS/DCS hybrid techniques allow us to examine skeletal muscle
hemodynamic changes during exercise and to further understand how the
muscle adapts during times of stress. In older adults the greatest improvement in
global VO2max was observed in aerobic training programs that were more than
20 weeks in duration with training intensities of 60-70% of VO2max [146]. With
aging, impairments of local microvascular oxygen delivery and exchange in
human skeletal muscle occur [142]. DeLorey et al. [147] observed that adaption
of regional muscle oxygen delivery was slower in older adults compared to
younger adults at the onset of a moderate-intensity exercise. In younger trained
adults a faster re-oxygenation (VO2 recovery time) of the muscle following an
exercise was observed compared with untrained adults [148]. Further, exercise
training in heart failure patients has been show to improve local muscle tissue
oxygenation [148]. However, as inactivity increases with aging it is important to
assess the relationship between physical activity levels, not exercise, and local
muscle tissue hemodynamics during increased energy demands.
Our retrospectively analysis was part of a double-blinded randomizedcontrolled trial, in which participants were enrolled into 1 of 4 groups: a combined
treatment of vitamin D repletion and aerobic training, vitamin D repletion alone,
aerobic training alone, or control conditions. In this trial we examined the
relationship between dietary fat intake and muscle lipid depots (IMCL and
EMCL). In addition, our objective was to determine the relationship between
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global VO2, physical activity levels, and local muscle tissue hemodynamics in
individuals 60 years of age or older.
4.3 Methods
4.3.1 Participants
Retrospective analyses were based on participants enrolled in the doubleblinded randomized, placebo-controlled trial. Both females and males, 60 years
of age or older, were recruited through word of mouth and local advertisements.
Exclusion criteria included history of myopathy and rhabdomyolysis, uncontrolled
hypertension, positive smoking status, inflammatory bowel disease, diabetes,
primary hyperparathyroidism, renal disease, or a measured BMI of <18.5 or
>34kg/m2. In addition, individuals with lower extremity injury or surgery 3 months
prior to study enrollment were excluded. Participants with a vitamin D (25(OH)D)
status of ≤32ng/mL and asymptomatic findings from the GXT were enrolled and
randomized to one of four study arms. The institutional review board approved
the study and written consent was obtained prior to study measures.
4.3.2 Study Design
Participants 60 years or older with vitamin D insufficiency (25(OH)D
<32ng/mL) were randomized to a 13 week double-blinded, four group design
intervention. Vitamin D3 (10,000IU x 5d/wk) or placebo was provided for 12
consecutive weeks. After the initial 12wk period, one additional week (7
consecutive days) with or without aerobic training was completed by both the
placebo and vitamin D supplementation groups (Figure 4.1). Screening visits
consisted of a blood draw to assess vitamin D status and a GXT to assess for
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any contraindication to study enrollment. Baseline measures (week 0) consisted
of anthropometry (height, weight, waist circumference) and PASE questionnaire.
At baseline and endpoint (week 13) participants completed MRI to assess
muscle lipid depots and NIRS/DCS measures during a foot plantar flexion
exercise to assess gastrocnemius’ hemodynamics. Accelerometry wear and
dietary recalls were completed at baseline, midpoint (week 7) and endpoint.
4.3.3 Statistical Analysis
Data were analyzed using IBM’s Statistical Package for the Social
Sciences (SPSS, version 22.0) and included descriptive statistics, independent ttest, analysis of variance (ANOVA), repeated measures analysis of variance
(RMANOVA), Person correlations, and linear regression. Independent t-test was
used to compare differences between participant characteristics. A RMANOVA
was employed to examine differences in dietary intake, physical activity levels,
and muscle lipid depots over time. Pearson correlation was used to assess the
relationship between 2 continuous variables. Stepwise linear regression was
employed to investigate the predictors of IMCL. Mean and SD were reported as
mean±SD and statistical significance was defined as p≤0.05.
4.4 Results
4.4.1 Participant Characteristics
This retrospective study included a total of 24 adults between the ages of
60 and 79. Baseline subject characteristics, age, BMI, and waist circumference
are described in Table 4.1. Participants’ educational attainment ranged from a
General Education Development (GED) to a doctoral degree and income range
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was between $11,500 and $210,000. BMI, weight, and waist circumference did
not significantly differ from baseline to endpoint in the total sample or among sex
groups.
4.4.2 Muscle Lipid Depots Characteristics
IMCL and EMCL measures over time (baseline to endpoint) were not
statistically different (Table 4.2). IMCL was positively correlated with age
(p=0.009) (Figure 4.2). IMCL did not differ between normal weight individuals and
those with a BMI>25kg/m2 at baseline. When compared with normal weight
individuals, EMCL was greater in individuals with a BMI≥25kg/m2 at baseline
(p=0.006) (Figure 4.3 (A)). At baseline, EMCL was positively correlated with BMI
(p=0.001) (Figure 4.3 (B)) and waist circumference (p<0.035) (Figure 4.3 (C)).
Baseline BMI was the best predictor of EMCL (p=0.002) independent of age or
time spent in moderate physical activity (Table 4.3). IMCL and EMCL were not
different between the 4 study groups at baseline.
4.4.3 Dietary Intake and Muscle Lipid Depots
Dietary intake including total energy (kcal), fat (g), carbohydrate (g),
protein (g) were not different between the 3 study time points (baseline, midpoint,
and endpoint) or by study groups. Total and percent energy, fat, and
carbohydrate intake are described in Table 4.4. Total and percent dietary fat
intake is described in Table 4.5. Males had a greater intake of total SFA
(p=0.008), PUFA (p=0.009), and MUFA (p=0.02) compared with females (Table
4.5). However, there were no differences in percent intake of dietary fats
between sexes. EMCL at baseline was positively correlated with percent calories
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from fat, which can be primarily attributed to SFA, as SFA was the only dietary
variable positively associated with EMCL (Figure 4.5). Although SFA was
positively correlated with EMCL, BMI remained the best predictor of EMCL
(Table 4.6).
PUFA to SFA ratio negatively correlated with endpoint IMCL (p=0.029).
IMCL content decreased in individuals that consumed a higher PUFA relative to
SFA diet (Figure 4.6). Endpoint 25(OH)D concentrations were not associated
with endpoint IMCL measures. A stepwise linear regression was employed
indicating that aerobic training and PUFA:SFA ratio were the only significant
predictors of IMCL (Table 4.6).
4.4.4 Physical Activity and Local Muscle Tissue Hemodynamics
During NIRS/DCS measures one participant was not compliant with
procedures because the participants continuously moved their leg throughout
testing and completed less than 30 seconds of the 3 minute arterial occlusion
protocol. Due to lack of compliance, the participant’s data was 1.5 times greater
than the interquartile range, and thus the participant was removed from
NIRS/DCS analysis. We observed no correlation between hemodynamic
measures and subject characteristics, age and BMI. There were no NIRS/DCS
measurement differences between males and females. Neither time spent in
moderate activity nor total activity were related with local tissue hemodynamics.
Further global of aerobic capacity, as measured during GXT, did not correlate
with local muscle tissue hemodynamics. PASE questionnaire scores were
negatively correlated with rVO2 during plantar flexion (p=0.048), 1 minute after

129

(p=0.05), and at full recovery (p=0.05) (Figure 4.7 A-C). A lower rBF was also
observed with greater PASE scores 1 minute after plantar flexion exercise
(p=0.059) and at full recovery (p=0.083).
4.5 Discussion
The aim of the study was to examine the relationship between dietary fat
intake and muscle lipid depots (IMCL and EMCL). In addition, we examined the
relationship between aerobic capacity, physical activity levels, and local muscle
tissue hemodynamics in healthy older adults enrolled in a randomized controlled
trial. Our primary finding was that a greater dietary SFA intake was positively
correlated with EMCL and a healthier dietary fat intake ratio (PUFA:SFA) was
negatively correlated with IMCL. Past studies examined the effects of short- and
long-term dietary interventions on muscle lipid depots. The novelty of this study
was that we examined the relationship between muscle lipid depots and daily
eating habits in a generally healthy older cohort. Further, in individuals that
reported higher activity levels, we observed lower gastrocnemius rBF and rVO2
during and after a plantar flexion exercise. These data suggest that a higher
PUFA:SFA diet is related with lower IMCL and potentially greater physical activity
levels may relate with local tissue hemodynamics.
We provide further evidence for age-associated increases in IMCL
content. Crane et al. [149] observed that older adults had higher IMCL content
and greater lipid droplet size along with a reduced number of muscle
mitochondria. Haus et al. [74] observed that older insulin resistant obese men
that engaged in a short exercise intervention (7 consecutive day of aerobic
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training) had increased IMCL and improved insulin sensitivity; however,
mitochondrial changes were not investigated. In addition to increased IMCL
content, improved mitochondrial oxidative capacity was seen in older adults
engaged in a longer (16wk) exercise regimen [77]. As a result of exercise
training, higher IMCL content was associated with insulin sensitivity [77].
Therefore, the importance of IMCL content is closely linked to the mitochondria’s
ability to metabolize lipid when needed, such as in time of exercise.
Both physical activity and dietary intake are modifiable lifestyle factors that
play a vital role in muscle health. Our participants’ dietary habits met the
Recommended Dietary Allowance (RDA) for percent caloric intake of
carbohydrate (45-65%), fat (20-35%), and protein (10-35%) [150]. On average,
females met the recommendations for SFA intake (≤10% from total calories),
while males consumed slightly more than the recommended amount (12%).
There are no current recommendations for unsaturated fatty acid intake, but it is
widely accepted that to reduce the risk of diseases, such as cardiovascular
disease or diabetes, reducing SFA to <10% of calories per day and replacing
SFA with unsaturated fatty acids is necessary [151].
Adipose tissue is the primary site of storage for excess caloric intake [30,
88]. During aging, a redistribution of fat depots occurs even if total body fat is
maintained [90]. Characteristically with aging, fat infiltrates various tissues such
skeletal muscle as fat storage sites change from the less deleterious
subcutaneous fat to visceral fat [30]. We observed a positive correlation between
increased SFA intake and EMCL. Although we observed that a higher dietary fat
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intake was related with increased EMCL, BMI remained the best predictor of
EMCL. In combination with previous data, our findings further support that
greater BMI is the major contributor to increased EMCL and that an overall
healthy lifestyle is necessary to maintain muscle health. Future studies should
focus to examine if weight loss can reduce EMCL.
We also observed that PUFA:SFA ratio intake was negatively correlated
with IMCL content. Since our findings were observed at endpoint we further
examine if the diet fat ratio or the study intervention was the best predictor of this
relationship. We observed that the best predictors of IMCL were both PUFA:SFA
ratio and aerobic training. Although our retrospective analysis was not able to
assess lipid turnover or mitochondrial oxidation, previous studies have shown
that a higher unsaturated fatty acid diet and exercise led to lower dietary fat
uptake by the muscle [84, 88, 89]. Jans et al. [89] suggested that these
observations may be due to the chylomicrons rich in PUFA and MUFA that were
more readily removed from the circulation by hepatic lipase instead of lipoprotein
lipase. The authors suggest that post-PUFA meal an improvement in
postprandial insulin sensitivity occurs compared with SFA, which would
decreases fatty acid uptake by the muscle. Lower muscle lipid uptake
accompanied by greater removal of the chylomicrons from the circulation would
potentially lead to a reduction in muscle fat accumulation and an increase in
muscle lipid turnover. Further, animal studies suggest that the type of fatty acids
consumed exert influence on the processing of the lipids during beta-oxidation.
Due to their chemical structure, unsaturated fatty acids seem to be preferentially
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oxidized over SFA [88]. Unsaturated fatty acids contain one or more double
bonds, whereas SFA do not contain double bonds. Double bonds are more
reactive and easily susceptible to modifications. These chemical structural
differences lead to unsaturated fatty acids’ preferential oxidation, which in turn
may lead to greater muscle lipid turnover and overall improved muscle health.
This was further seen in normal weight individuals who had a greater degree of
unsaturation compared with those in a higher BMI category [84]. Synthesis of
unsaturated fatty acids through desaturation of SFA was decreased in
overweight and obese individuals. The reduced degree of unsaturation in
overweight and obese individuals may be involved in increased lipid peroxidation
and damage to the myocytes. Combining our retrospective findings with previous
studies, these data suggest that maintaining a healthy diet, in particular partially
replacing SFA with healthier fats (PUFAs and MUFAs), may play a beneficial role
in muscle health.
Higher levels of physical activity are important to preserve muscle health
and function. We examined the relationship between gastrocnemius
hemodynamics during a foot plantar flexion exercise with physical activity levels
measured by accelerometry and PASE questionnaire and global oxygen
consumption measured during a GXT. Although participants moderate physical
activity levels, measured by accelerometry wear, ranged from 20min/d to
108min/d, the majority (82%) of the participants met the CDC’s guideline for
moderate physical activity [125]. Further, accelerometry vector magnitude
counts, a continues variable was examined, but was not related with local muscle
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tissue metabolism. The lack of variance in physical activity could have precluded
our ability to detect a relationship between low and high moderate physical
activity levels and local muscle tissue hemodynamics.
In addition, we examined the relationship between peak VO2, measured
by GXT, and local tissue hemodynamics. Peak VO2 measures provide
information about cardiovascular health and in our sample we had a large
distribution (15-50mL/kg/min), of which 45.8% of participants had poor to fair
cardiovascular fitness. Global oxygen consumption impairments are not always
apparent and the need to examine microvascular changes is necessary because
it can provide more nuanced assessment of physiological changes associated
with aging [152]. Marengi et al. [153] observed that younger adults a tight
correlation between global and local VO2 exists. The authors simultaneously
measured local VO2 of the vastus lateralis and global VO2 during a graded cycle
ergometry test performed until volitional fatigue. The discrepancy between our
findings may be attributed to multiple factors. We did not complete global and
local VO2 measures simultaneously. Our global VO2 measures taken during a
graded treadmill exercise test and local gastrocnemius VO2 measures were
completed during a plantar flexion exercise. Participants were also instructed to
continue the GXT until volitional fatigue, but the foot plantar flexion protocol was
set to 75 repetitions, in which participants may not have reached exhaustion.
Therefore, it was not surprising that we did not observe a relationship between
peak VO2 and local VO2 as measured by NIRS/DCS.
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Based on PASE questionnaire findings, we observed that individuals that
reported engaging in more physical activity had lower rVO2 during, immediately
after, and at full recovery of the foot plantar flexion exercise. In individuals that
were more active, muscles may be more adapt to increases in demand;
therefore, during periods of stress the relative increase in BF and VO2 was lower
during and after exercise compared with less active individuals. We observed
that physical activity was the best predictor of rVO2 independent of BMI and age.
Although the significance of our findings was that greater physical activity levels
in older adults may be helpful in preventing microvascular dysfunction that occurs
with aging, these results should be interpreted conservatively.
There are multiple limitations to our findings. First, only PASE
questionnaire was correlated with local muscle tissue oxygen consumption and
blood flow. The PASE questionnaire is a reliable and valid assessment of
physical activity in older adults; however accelerometry is a better measure. As
accelerometry data did not correlate with local muscle tissue metabolism the
relationship between physical activity and local muscle tissue still remains
unclear. Future studies should aim to further the understand of how physical
activity, not exercise, may contribute to local muscle oxygen use and impact
overall heath. Our findings show a relationship between aerobic training,
favorable dietary fat intake and lower IMCL. However, the impact of these
relationships on overall health warrants further investigations.
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Figure 4.1 Study Design
The randomized double-blinded placebo-controlled trial consisted of 4
arms. Vitamin D insufficient (25(OH)D≤32ng/mL) 60 years of age or older
individuals were recruited to participant in the 13 week trial. Participants were
randomized to one of four groups 1) vitamin D supplementation + aerobic
training, 2) vitamin D supplementation + no aerobic training, 3) placebo + aerobic
training, 4) placebo + no aerobic training.
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Table 4.1 Subject Characteristics, Mean±SD
Female
(n= 12)
68.8±6
164.6±5*
66.4±12*
24.5±4
82.9±14*

Male
(n= 12)
65.6±4
177.8±6*
83.4±14*
26.2±3
96.4±11*

Total
(n=24)
67.2±5
171.2±9
74.9±15
25.3±4
89.6±14

Age (years)
Height (cm)
Weight (kg)
BMI (kg/m2)
Waist Circumference (cm)
Ethnicity
White
12
11
African American
0
1
SES (n=24)
High School Graduate or GED
2
2
Some College, No Degree
0
1
Associates Degree
1
0
Bachelor's Degree
4
2
Master's Degree
2
4
Doctoral Degree
3
3
Income ($; n=21)
<35,000
2
1
35,000 ≤ 50,000
2
0
50,000 ≤ 100,000
5
4
100,000 ≤ 150,000
1
4
>150000
1
1
*Significant differences between females and males (p<0.05)
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23
1
4
1
1
6
6
6
3
2
9
5
2

Table 4.2 EMCL and IMCL Characteristics
Muscle Lipid Depots
IMCL Baseline (au)

Females
(n=12)
0.44±0.28

Males
(n=12)
0.38±0.2

Total
(n=24)
0.41±0.24

IMCL Endpoint (au)

0.37±0.24

0.34±0.22

0.35±0.22

EMCL Baseline (%)

26.2±6

26±4

26.1±5

EMCL Endpoint (%)

25.9±5

25±5

25.4±5
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Table 4.2 EMCL and IMCL Characteristics
IMCL and EMCL was not different between males and females. Muscle
lipid depots at baseline and endpoint were not different in total sample or
between sexes.
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Gastrocnmeius IMCL (x100)
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Figure 4.2 Relationship between IMCL and age
A significant positive linear relationship was observed between IMCL and
age. The older the participants were the higher their gastrocnemius IMCL
content.
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Figure 4.3 The relationship between EMCL, BMI, and waist circumference
EMCL content was statistically lower in normal weight vs.
overweight+obese individuals at baseline and at end study (A). EMCL was
positively correlated with BMI (B) and waist circumference (C).
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Table 4.3 Variables that predict EMCL

Predictor Variable

Estimate (Standardized
Coefficients (Beta))

p-value

Moderate Physical Activity

0.055

0.774

Age

-0.048

0.962

BMI

0.652

0.002
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Table 4.3 Variables that predict EMCL
Age and time spend in moderate activity were not significant predictors of
EMCL content. Higher BMI levels were a significant predictor of greater EMCL
content.
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Table 4.4 Dietary intake between sexes, mean±SD

Female (n=12)

Male (n=12)

Total (n=24)

Energy (kcal)

1510±353*

2055±736*

1782.7±630

Fat (g)

56.7±19*

82.6±31*

69.7±28

% Calories from Fat 32±4

34.9±5

33.5±5

Carbohydrate (g)

185.7±42

245.2±94

215.5±78

% Calories from
Carbohydrate

48.2±6

46.9±7

47.6±7

Protein (g)

65.1±16

77.3±27

71.2±23

% Calories from
Protein

17.7±4

15.3±3

16.5±4

*Significant differences between females and males (p<0.05)
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Table 4.5 Dietary fat intake between sexes, mean±SD
Female (n=12)

Male (n=12)

Total (n=24)

SFA (g)

18.4±7*

27.7±11*

23±10

% Calories from SFA

10.3±2

11.8±2

11.1±2

PUFA (g)

12.9±4*

19.6±9*

16.3 8

% Calories PUFA

7.3±1

8±2

7.7±2

MUFA (g)

20.6±7*

28.5±10*

24.6±9

% Calories MUFA

11.6±2

12.2±2

11.9±2

PUFA to SFA ratio

0.84±0.3

0.78±0.2

0.81±0.2

* Significant differences between females and males (p<0.05)
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Figure 4.4 Relationship between percent calories from fat and EMCL
A positive linear relationship was observed between intake of percent
calories from total fat (A) and saturated fat (B) and EMCL. Individuals with a
higher consumption saturated and total fat had greater EMCL content.
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Table 4.6 Variables that predictors of EMCL when adjusting for SFA intake

Predictor Variable

Estimate (Standardized
Coefficients (Beta))

p-value

Moderate Physical Activity

0.033

0.863

Age

-0.043

0.820

BMI

0.562

0.009

% calories from SFA

0.234

0.235
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Table 4.6 Variables that predictors of EMCL when adjusting for SFA intake
Age, SFA, and time spend in moderate physical activity were not
significant predictors of EMCL content. Higher BMI levels were a significant
predictor of greater EMCL content.
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Figure 4.5 Relationship between PUFA to SFA Ratio and IMCL
A negative linear relationship was observed between an average intake of
PUFA to SFA and endpoint IMCL measures. Individuals with a higher
consumption of PUFA relative to SFA intake had lower IMCL content.

154

Table 4.7 Variables that predict IMCL

Predictor Variable

Estimate (Standardized
Coefficients (Beta))

Aerobic Training
PUFA:SFA ratio

-0.383
-0.484
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p-value

0.046
0.014

Table 4.7 Variables that predict IMCL
The stepwise linear regression indicated that aerobic training and greater
intake of PUFA:SFA significantly predict IMCL content.
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Figure 4.6 Relationship between PASE questionnaire and local muscle
hemodynamics
A significant negative linear relationship was observed between PASE
questionnaire scores and rVO2 during (A), 1 minute after (B), and at full recovery
(C) of the plantar flexion exercise.
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Chapter 5: General Discussion
5.1 Discussion
During the aging process muscle strength and function decline, but
modifiable lifestyle factors can play a key role in alleviating muscle dysfunction.
Additionally, age-associated muscle lipid depot changes can negatively affect
muscle health and function. Higher EMCL content has been associated with
reduced muscle strength and function in older adults [30, 55]. Likewise, higher
IMCL content in combination with low IMCL turnover has been linked to greater
insulin resistance [141]. Dietary intake, vitamin D status, and exercise have been
associated with muscle lipid depots. Previous work has observed an inverse
relationship between 25(OH)D concentrations and EMCL [55, 86] and our lab
has observed a positive linear relationship between 25(OH)D concentrations and
IMCL in healthy older adults [59]. For our first objective, we examined the
relationship between muscle lipid depots, vitamin D status, and physical function.
No significant relationship between 25(OH)D concentrations and IMCL content
was observed; however, in accordance with previous studies [55, 86] a
significant negative relationship between EMCL content and 25(OH)D
concentrations was noted. Further in females, lower EMCL content and higher
25(OH)D concentrations were significant predictors of faster FSST times
independent of age and BMI. These observational data suggest that maintaining
higher vitamin D status may play a role in lowering EMCL and positively
impacting physical function.
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Exercise can positively influence overall muscle health by lowering EMCL
content and increasing IMCL turnover [30, 141]. Previous studies have observed
muscle lipid depots changes in younger and older adults enrolled in an exercise
intervention [44, 74, 77, 95]. However, we aimed to examine the relationship
between daily physical activity levels and muscle lipid depots. We used multiple
methods to measure physical activity levels and no relationship was observed
between physical activity and muscle lipid depots. These results may suggest
that increased daily physical activity alone may not be enough to contribute to
healthful alteration in muscle lipid depots. Higher-intensity, structured exercise
regimens may be necessary to alter muscle lipid depots. However, the
relationship between physical activity and muscle lipid depots warrants further
investigation, as our sample was relatively small and lacked variance in physical
activity levels.
Similar to vitamin D and physical activity, BMI is another modifiable
lifestyle factor that can influence muscle lipid depots. Previous studies observed
a relationship between higher BMI categories and greater IMCL and EMCL
content [79, 84]. Also, greater BMI has been associated with lower vitamin D
status [39, 43]. We further assessed these relationships in a cohort of adults 60
years of age or older. Although our findings were not significant, we observed
increases in muscle lipid depots with increases in BMI category. We observed
lower vitamin D status in higher BMI categories and a significant negative
correlation between 25(OH)D concentrations and central adiposity measured by
waist circumference. We observed a positive relationship between EMCL and
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BMI in the cohort enrolled in the randomized double-blinded placebo-controlled
trial. BMI was also a significant predictor of EMCL when adjusting for physical
activity levels and age. Together these data suggest that without exercise, higher
BMI and central adiposity, relate to muscle lipid depots accumulation and may
potentially leave higher BMI individuals more susceptible to lower vitamin D
status.
In addition to the aforementioned modifiable lifestyle factors, dietary intake
can influence muscle lipid depots. We retrospectively analyzed the relationship
between dietary intake and muscle lipid depots in participants enrolled in a
double-blinded randomized controlled-trial. Ectopic fat accumulation was
observed in skeletal muscle of individuals with an overweight or obese BMI
classification [30]. In addition, changes in fat distribution, independent of body
weight and waist circumference, occur with aging with increased fat deposition
seen in the skeletal muscle [154]. Increases in fat storage, decline in
mitochondria content and function, and poor capacity for oxidative metabolism
leaves older adults susceptible to increased EMCL content and stagnant IMCL
content [72, 74, 77].
Adding to previous findings [30], we observed a positive relationship
between increased EMCL and dietary fat intake. Also for the first time to our
knowledge, a relationship between increased PUFA:SFA dietary intake and
decreased IMCL was observed. Further, the aerobic training program and
increased dietary intake of PUFA:SFA were the best predictors of IMCL. Both
human and animal dietary intervention trials have observed a relationship
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between greater unsaturated fatty acids and higher IMCL turnover [84, 88, 89].
Combining our data with previous findings, these results may suggest that
individuals that consume a higher unsaturated fatty acid diet in combination with
aerobic exercise, may have lower lipid accumulation potentially due to greater
lipid turnover.
We did not assess lipid turnover, but we used NIRS/DCS measures to
monitor microvascular hemodynamic changes during a foot plantar flexion
exercise this provided us with an index to monitor local muscle tissue
hemodynamics. Individuals that reported engaging in more physical activity had
lower rBF and rVO2 during and after the foot plantar flexion exercise. These
findings may due to active individuals being more acclimated to increases in
muscle demand and therefore having a relatively lower hemodynamic response
compared with less active individuals. This would suggest that greater physical
activity levels and not necessarily exercise may help to prevent microvascular
dysfunction that occurs naturally with aging.
5.2 Limitations
A major limitation of this dissertation was the nature of a retrospective
study analysis. A retrospective study uses data that has previously been
documented and may not be related to the research aims [155]. The first specific
aim, used combined datasets from 3 different trials. Participants were recruited
over a 4 year period and completed varied study measures. Incomplete data was
inevitable, as waist circumference, DXA, CT, and FSST measures were not
completed for each individual trial. Also, physical activity levels were difficult to
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compare across the total sample as diverse assessment methods were
implemented to measure physical activity levels. Physical activity levels were
measured either by using a physical activity questionnaire, accelerometry wear,
or PASE questionnaire. Although the physical activity questionnaire inquired
about frequency, duration, and intensity of exercise the nature of an open-ended
question may have led to varied subjective responses. For example, one
question inquired if participants exercised and if so to provide additional detail.
This type of open-ended question allowed for individuals’ to subjectively
determine whether their activities constituted as exercise or physical activities of
daily living.
A major limitation in both aims was that the data was underpowered for
some variables due to the small sample size. Between both aims and generally
among the literature racial diversity is lacking. Our study participants were
primarily White and since genetic factors may play a role in the interpretation of
vitamin D status there is a need to investigate these relationships in all races.
Further, currently no gold standard exists for the analysis and reporting of IMCL
and EMCL, therefore muscle lipid depots can be difficult to review across studies.
5.3 Significance and Implications
The findings from both aims support previous literature and provide new
information about the relationship between modifiable lifestyle factors and muscle
lipid depots in older adults. First, we were able to provide further evidence for the
associations between 25(OH)D concentrations, EMCL, and physical function.
Although not significant, similar to previous findings we observed a relationship
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between increased muscle lipid depots and BMI categories. Decreased 25(OH)D
concentrations in higher BMI categories provide further evidence to the
established relationship. In both animal and human models, studies have
focused on dietary fat interventions with varied fat composition and study
duration. The novelty of our findings was that we examined the relationship
between muscle lipid and daily dietary habits. Even without any supplemental
dietary intervention, we observed that higher IMCL was related with increased
daily intake of PUFA:SFA. In combination, a higher daily unsaturated fatty acid
diet and exercise were significant predictors of IMCL content, which was
consistent with previous work that examined dietary and exercise interventions
on IMCL turnover.
With observational retrospective data, we were able to provide information
about the relationships between our variables. Future intervention trials are
needed to examine the cause and effect between modifiable lifestyle factors and
muscle lipid depots in older adults. Further, both animal and human studies need
to focus on identifying mechanisms related to how modifiable lifestyles factors
may cause favorable lipid changes (EMCL decreases and increased IMCL
turnover).
5.4 Future Directions
The findings from our study demonstrate that modifiable lifestyles factors
relate with age-associated alterations in muscle lipid depots. However, as our
results were observational in nature, future studies should consider a more
robust study design aimed to examine the effect of lifestyles factors on
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deleterious muscle lipid accumulation. Further, studies should be appropriately
powered and include both females and males of varied age and diverse races.
The discrepancy between our previous work [59] and our current findings
regarding IMCL and 25(OH)D concentrations warrant further investigation. Future
studies should examine the effect of vitamin D supplementation in vitamin D
deficient older adults on muscle lipid depots changes and physical function. Due
to the dynamic nature of IMCL, it is important to measure muscle lipid turnover
and mitochondrial function as well as IMCL quantity. Further, multiple physical
function measures should be completed in order to provide a comprehensive
approach to assess muscle strength and performance. It is also important to
discern between daily physical activity and structured exercise and the role
physical activity may play on age-associated muscle lipid depots. Less active
older populations may be more receptive and compliant to meeting physical
activity goals compared with initiating and maintaining a rigorous exercise
regimen. Therefore, the effect of physical activity on muscle lipid depots needs to
be further investigated.
Dietary intake should also be considered when assessing muscle lipid
depots. Unsaturated fatty acids seem to have a favorable effect on muscle lipid
depots and turnover; however human dietary fat interventions are necessary to
examine the effect of a high unsaturated fatty acid diet on muscle lipid depot
changes and overall health. Finally, with aging microvascular changes were
observed and future studies should incorporate novel techniques, such as
NIRS/DCS, to assess the effect of modifiable lifestyle factors on local muscle
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tissue changes. Taken together, our findings show that modifiable lifestyles
factors (BMI, vitamin status, physical activity, and dietary fat intake) relate with
muscle lipid metabolism and may contribute to overall health and quality of life in
older adults.
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Appendices
A.1 MRI Screening Form for Participants

167

168

A.2 NIRS/DCS formulas
NIRS for oxygenation measurement:
Total hemoglobin concentrations [tHb]: [tHb] = [HbO2] + [Hb]
Tissue blood oxygen saturation (StO2): StO2 = 100% x ([HbO2]/[tHb])
DCS for blood flow measurement:
Relative blood flow (rBF): rBF = (BFI)/(BFIbaseline)
Hybrid NIRS/DCS measurement:
(1) VO2 = BF x ([O2]a – [O2]v)
(2) OEF = ([O2]a – [O2]v)/[O2]a
(3) combining equation (1) and (2): VO2 = OEF x BF x ([O2]a)
(4) relative change (rVO2, rOEF, rBF, (r[O2]a)) can be determined by dividing the
baseline value: rVO2 = rOEF x rBF x (r[O2]a)
(5) assuming [O2]a is constant: rVO2 = rOEF x rBF
(6) OEF = (SaO2 – StO2)/(γ x SaO2)
(7) assuming γ is constant and SaO2 is constant at 100%:
rOEF = (1 – StO2) / (1 – StO2 baseline)
(8) rVO2 = rBF x (1 – StO2) / (1 – StO2 baseline)
Abbreviation
BFI

Blood flow index

[O2]a

Arterial oxygen concentration

[O2]v

Venous oxygen concentration

OEF

Oxygen extraction fraction

VO2

Oxygen consumption rate

γ

% of blood volume contained in the venous compartment of
the vascular system
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A.3 Medical History Questionnaire
YES NO

1. Is your doctor currently prescribing drugs (for example,
water pills) for your blood pressure, heart, or any other
condition?
Medicines/dosage:
Taken For:

YES NO

2. Do you know of any other reason (such as any
neuromuscular or metabolic disorders, eg diabetes,
breathing issues, asthma or emphysema) why you
should not do physical activity?
List:

YES NO

3. Are you currently seeing your doctor or health care
provider for any reason? If yes, please explain any
findings (heart murmur, abnormal pulmonary findings
etc):
List:

YES NO

4. Do you currently smoke (or have a history of smoking) or
use tobacco products? When did you last quit?

170

YES NO

YES NO

5. Is there any family history of pulmonary, metabolic
disease, stroke, or sudden death?
If yes, please list:

6. Any other known allergies (medications, food, latex, etc)
If yes, please list:

YES NO

7. Do you have any chronic illnesses or known viruses
(hepatitis, HIV) etc?
If yes, please explain:

YES NO

8. Have you had any surgeries of any kind?
If yes, please list type, reason and year:
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YES NO

9. Are you taking any over the counter medications, dietary
supplements (vitamins or minerals (multivitamins)?
Please list both type/dosage and reason for taking
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A.4 Physical Activity Readiness questionnaire (PAR-Q)
Common sense is your best guide when you answer these questions. Please
read the questions carefully and answer each one honestly; circle YES or NO.
YES NO

1. Has your doctor ever said that you have a heart
condition/high blood pressure and that you should
only do physical activity recommended by a doctor?

YES NO

2. Do you feel pain (tingling, heaviness, burning,
tightness, squeezing) in your chest when you do
physical activity?
List any heart condition here:
__________________________________________

YES NO

3. In the past month, have you had chest pain when
you were not doing physical activity?

YES NO

4. Do you lose your balance because of dizziness or
do you ever lose consciousness?

YES NO

5. Do you have an orthopedic (bone or joint) problems
that could be made worse by a change in your
physical activity?
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A.5 AHA/ACSM Health/Fitness Screening Questionnaire
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A.6 Physical Activity Questionnaire
In terms of physical demands,
how would you rate your
lifestyle?

Sedentary
Slightly Active
Active
Very Active

In terms of physical or muscular
demands, how would you rate
your workplace?

Sedentary
Slightly Active
Active
Very Active
Not Applicable

Are you currently exercising?

YES
NO

What type of exercise do you
participate in regularly?

Resistance
Cardio
Resistance and Cardio

How many times per week do
you participate in these types of
exercise?

If resistance training, please
briefly describe your typical
workout (full body, one muscle
group per day, intensity,
duration etc):

Please list any other activities
below:
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A.7 GXT Data Collection Form
Subject id:

Date:

Resting Data:
HR

BP

Angina?

Graded Exercise Testing
Stage Workload

Min

HR

BP

Speed/Incline

RPE
Chest/Legs/Overall

1

2.2

0%

0-2

2

2.6

0%

2-4

3

3.0

2

4-6

4

3.4

4

6-8

5

3.8

6

8-10

6

4.2

8

10-12

7

4.6

10

12-14

8

5.0

12

14-16

9

5.4

14

16-18

10

5.8

16

18-20
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Angina?

Recovery
Workload

Min

HR

BP

Angina?

Speed/Incline
0

0%

1

0

0%

3

0

0%

5

Notes:
Form completed by:____________________
Testing completed by:___________________
Notes:_________________________________________________________
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A.8 Aerobic Training Data Collection Form

Subject Id:

Date/Time:

Session:
Weight:
Target heart rate:
Study personnel:

BP before AT:

BP after AT:

HR before AT:

HR after AT:

Min

Workload
Speed/Incline

Average
HR

178

Comments

References
1.

Deluca, H.F., History of the discovery of vitamin D and its active
metabolites. Bonekey Rep, 2014. 3: p. 479.

2.

Shils, M.E., et al., Modern Nutrition in Health and Disease. 10 ed, ed. L.W.
Wilkins. 2006, Philadelphia.

3.

Sahay, M. and R. Sahay, Rickets-vitamin D deficiency and dependency.
Indian J Endocrinol Metab, 2012. 16(2): p. 164-76.

4.

Holick, M.F., Vitamin D Is Not as Toxic as Was Once Thought: A Historical
and an Up-to-Date Perspective. Mayo Clin Proc, 2015. 90(5): p. 561-4.

5.

Craviari, T., et al., Rickets: an overview and future directions, with special
reference to Bangladesh. A summary of the Rickets Convergence Group
meeting, Dhaka, 26-27 January 2006. J Health Popul Nutr, 2008. 26(1): p.
112-21.

6.

Heaney, R.P., Vitamin D: criteria for safety and efficacy. Nutr Rev, 2008.
66(10 Suppl 2): p. S178-81.

7.

Wintermeyer, E., et al., Crucial Role of Vitamin D in the Musculoskeletal
System. Nutrients, 2016. 8(6).

8.

McCarthy, E.K. and M. Kiely, Vitamin D and muscle strength throughout
the life course: a review of epidemiological and intervention studies. J
Hum Nutr Diet, 2015. 28(6): p. 636-45.

9.

Budui, S.L., A.P. Rossi, and M. Zamboni, The pathogenetic bases of
sarcopenia. Clin Cases Miner Bone Metab, 2015. 12(1): p. 22-6.

10.

Houghton, L.A. and R. Vieth, The case against ergocalciferol (vitamin D2)
as a vitamin supplement. Am J Clin Nutr, 2006. 84(4): p. 694-7.

11.

Holick, M.F., Vitamin D status: measurement, interpretation, and clinical
application. Ann Epidemiol, 2009. 19(2): p. 73-8.

12.

Fuleihan Gel, H., et al., Serum 25-Hydroxyvitamin D Levels: Variability,
Knowledge Gaps, and the Concept of a Desirable Range. J Bone Miner
Res, 2015. 30(7): p. 1119-33.

13.

Wootton, A.M., Improving the measurement of 25-hydroxyvitamin D. Clin
Biochem Rev, 2005. 26(1): p. 33-6.

179

14.

Yousefzadeh, P., S.A. Shapses, and X. Wang, Vitamin D Binding Protein
Impact on 25-Hydroxyvitamin D Levels under Different Physiologic and
Pathologic Conditions. Int J Endocrinol, 2014. 2014: p. 981581.

15.

Powe, C.E., et al., Vitamin D-binding protein and vitamin D status of black
Americans and white Americans. N Engl J Med, 2013. 369(21): p. 19912000.

16.

Nielson, C.M., et al., Free 25-Hydroxyvitamin D: Impact of Vitamin D
Binding Protein Assays on Racial-Genotypic Associations. J Clin
Endocrinol Metab, 2016. 101(5): p. 2226-34.

17.

Alzaman, N.S., et al., Vitamin D status of black and white Americans and
changes in vitamin D metabolites after varied doses of vitamin D
supplementation. Am J Clin Nutr, 2016. 104(1): p. 205-14.

18.

Lips, P., Relative value of 25(OH)D and 1,25(OH)2D measurements. J
Bone Miner Res, 2007. 22(11): p. 1668-71.

19.

Bikle, D.D., Vitamin D metabolism, mechanism of action, and clinical
applications. Chem Biol, 2014. 21(3): p. 319-29.

20.

Hewison, M., et al., 1alpha-Hydroxylase and the action of vitamin D. J Mol
Endocrinol, 2000. 25(2): p. 141-8.

21.

Kumar, R. and J.R. Thompson, The regulation of parathyroid hormone
secretion and synthesis. J Am Soc Nephrol, 2011. 22(2): p. 216-24.

22.

Kopic, S. and J.P. Geibel, Gastric acid, calcium absorption, and their
impact on bone health. Physiol Rev, 2013. 93(1): p. 189-268.

23.

National Institute of Health Office of Dietary Supplements. Vitamin D: Fact
Sheet for Health Professionals. 2016.

24.

Holick, M.F., Vitamin D deficiency. N Engl J Med, 2007. 357(3): p. 266-81.

25.

Holick, M.F., Vitamin D: a D-Lightful health perspective. Nutr Rev, 2008.
66(10 Suppl 2): p. S182-94.

26.

Institute of Medicine of the National Academies, Dietary Reference Intake
for Calcium and Vitamin D. 2011.

27.

Holick, M.F., et al., Evaluation, treatment, and prevention of vitamin D
deficiency: an Endocrine Society clinical practice guideline. J Clin
Endocrinol Metab, 2011. 96(7): p. 1911-30.

28.

Hossein-nezhad, A. and M.F. Holick, Vitamin D for health: a global
perspective. Mayo Clin Proc, 2013. 88(7): p. 720-55.

180

29.

Ekwaru, J.P., et al., The importance of body weight for the dose response
relationship of oral vitamin D supplementation and serum 25hydroxyvitamin D in healthy volunteers. PLoS One, 2014. 9(11): p.
e111265.

30.

Addison, O., et al., Intermuscular fat: a review of the consequences and
causes. Int J Endocrinol, 2014. 2014: p. 309570.

31.

Thrailkill, K.M., et al., Enhanced excretion of vitamin D binding protein in
type 1 diabetes: a role in vitamin D deficiency? J Clin Endocrinol Metab,
2011. 96(1): p. 142-9.

32.

Ying, H.Q., et al., Circulating vitamin D binding protein, total, free and
bioavailable 25-hydroxyvitamin D and risk of colorectal cancer. Sci Rep,
2015. 5: p. 7956.

33.

Kaeslin, M.A., et al., Do Postmenopausal Women Have Higher Serum 25Hydroxyvitamin D3 Concentrations Compared to Men or Younger
Women? . Autacoids 2014. 3(107).

34.

Lutsey, P.L., et al., Race and Vitamin D Binding Protein Gene
Polymorphisms Modify the Association of 25-Hydroxyvitamin D and
Incident Heart Failure: The ARIC (Atherosclerosis Risk in Communities)
Study. JACC Heart Fail, 2015. 3(5): p. 347-56.

35.

Yuen, A.W. and N.G. Jablonski, Vitamin D: in the evolution of human skin
colour. Med Hypotheses, 2010. 74(1): p. 39-44.

36.

Engelsen, O., The relationship between ultraviolet radiation exposure and
vitamin D status. Nutrients, 2010. 2(5): p. 482-95.

37.

Mutt, S.J., et al., Vitamin D and adipose tissue-more than storage. Front
Physiol, 2014. 5: p. 228.

38.

Scott, D., et al., Vitamin d and physical activity status: associations with
five-year changes in body composition and muscle function in communitydwelling older adults. J Clin Endocrinol Metab, 2015. 100(2): p. 670-8.

39.

Mallard, S.R., A.S. Howe, and L.A. Houghton, Vitamin D status and weight
loss: a systematic review and meta-analysis of randomized and
nonrandomized controlled weight-loss trials. Am J Clin Nutr, 2016.

40.

Cassity, E.P., et al., The effect of body composition and BMI on 25(OH)D
response in vitamin D-supplemented athletes. Eur J Sport Sci, 2016.
16(7): p. 773-9.

181

41.

Drincic, A.T., et al., Volumetric dilution, rather than sequestration best
explains the low vitamin D status of obesity. Obesity (Silver Spring), 2012.
20(7): p. 1444-8.

42.

Wortsman, J., et al., Decreased bioavailability of vitamin D in obesity. Am
J Clin Nutr, 2000. 72(3): p. 690-3.

43.

Pereira-Santos, M., et al., Obesity and vitamin D deficiency: a systematic
review and meta-analysis. Obes Rev, 2015. 16(4): p. 341-9.

44.

Grant, W.B. and M.F. Holick, Benefits and requirements of vitamin D for
optimal health: a review. Altern Med Rev, 2005. 10(2): p. 94-111.

45.

Heaney, R.P., Functional indices of vitamin D status and ramifications of
vitamin D deficiency. Am J Clin Nutr, 2004. 80(6 Suppl): p. 1706S-9S.

46.

Schwartz, J.B., L. Kane, and D. Bikle, Response of Vitamin D
Concentration to Vitamin D3 Administration in Older Adults without Sun
Exposure: A Randomized Double-Blind Trial. J Am Geriatr Soc, 2016.
64(1): p. 65-72.

47.

Shuler, F.D., et al., Sports health benefits of vitamin d. Sports Health,
2012. 4(6): p. 496-501.

48.

McDonnell, S.L., et al., Serum 25-Hydroxyvitamin D Concentrations >/=40
ng/ml Are Associated with >65% Lower Cancer Risk: Pooled Analysis of
Randomized Trial and Prospective Cohort Study. PLoS One, 2016. 11(4):
p. e0152441.

49.

Rosendahl-Riise, H., et al., Vitamin D supplementation and its influence
on muscle strength and mobility in community-dwelling older persons: a
systematic review and meta-analysis. J Hum Nutr Diet, 2016.

50.

Sohl, E., et al., Vitamin D status is associated with functional limitations
and functional decline in older individuals. J Clin Endocrinol Metab, 2013.
98(9): p. E1483-90.

51.

Shinkov, A., et al., Differences in the prevalence of vitamin D deficiency
and hip fractures in nursing home residents and independently living
elderly. Arch Endocrinol Metab, 2016. 60(3): p. 217-22.

52.

Mosekilde, L., Vitamin D and the elderly. Clin Endocrinol (Oxf), 2005.
62(3): p. 265-81.

53.

Daly, R.M., Independent and combined effects of exercise and vitamin D
on muscle morphology, function and falls in the elderly. Nutrients, 2010.
2(9): p. 1005-17.

182

54.

Ortman J.M., V. V.A., and H. Hogan, An Aging Nation: The Older
Population in the United States, in census.goc, U.S.C. Bureau, Editor.
2014.

55.

Tagliafico, A.S., et al., Relationship between fatty degeneration of thigh
muscles and vitamin D status in the elderly: a preliminary MRI study. AJR
Am J Roentgenol, 2010. 194(3): p. 728-34.

56.

Zoico, E., et al., Adipose tissue infiltration in skeletal muscle of healthy
elderly men: relationships with body composition, insulin resistance, and
inflammation at the systemic and tissue level. J Gerontol A Biol Sci Med
Sci, 2010. 65(3): p. 295-9.

57.

Burton, L.A. and D. Sumukadas, Optimal management of sarcopenia. Clin
Interv Aging, 2010. 5: p. 217-28.

58.

Visser, M., D.J. Deeg, and P. Lips, Low vitamin D and high parathyroid
hormone levels as determinants of loss of muscle strength and muscle
mass (sarcopenia): the Longitudinal Aging Study Amsterdam. J Clin
Endocrinol Metab, 2003. 88(12): p. 5766-72.

59.

Redzic, M., D.K. Powell, and D.T. Thomas, Vitamin D status is related to
intramyocellular lipid in older adults. Endocrine, 2014. 47(3): p. 854-61.

60.

Toffanello, E.D., et al., Vitamin D and physical performance in elderly
subjects: the Pro.V.A study. PLoS One, 2012. 7(4): p. e34950.

61.

Bischoff-Ferrari, H.A., et al., Higher 25-hydroxyvitamin D concentrations
are associated with better lower-extremity function in both active and
inactive persons aged > or =60 y. Am J Clin Nutr, 2004. 80(3): p. 752-8.

62.

Ellis, A.C., et al., Cardiorespiratory fitness in older adult women:
relationships with serum 25-hydroxyvitamin D. Endocrine, 2014. 47(3): p.
839-44.

63.

Sinha, A., et al., Improving the vitamin D status of vitamin D deficient
adults is associated with improved mitochondrial oxidative function in
skeletal muscle. J Clin Endocrinol Metab, 2013. 98(3): p. E509-13.

64.

Roussel, M., et al., 31P magnetic resonance spectroscopy study of
phosphocreatine recovery kinetics in skeletal muscle: the issue of
intersubject variability. Biochim Biophys Acta, 2000. 1457(1-2): p. 18-26.

65.

Ceglia, L., et al., A randomized study on the effect of vitamin D(3)
supplementation on skeletal muscle morphology and vitamin D receptor
concentration in older women. J Clin Endocrinol Metab, 2013. 98(12): p.
E1927-35.

183

66.

Pojednic, R.M. and L. Ceglia, The emerging biomolecular role of vitamin D
in skeletal muscle. Exerc Sport Sci Rev, 2014. 42(2): p. 76-81.

67.

Boland, R.L., VDR activation of intracellular signaling pathways in skeletal
muscle. Mol Cell Endocrinol, 2011. 347(1-2): p. 11-6.

68.

Ceglia, L. and S.S. Harris, Vitamin D and its role in skeletal muscle. Calcif
Tissue Int, 2013. 92(2): p. 151-62.

69.

Bischoff-Ferrari, H.A., et al., Vitamin D receptor expression in human
muscle tissue decreases with age. J Bone Miner Res, 2004. 19(2): p. 2659.

70.

Pojednic, R.M., et al., Effects of 1,25-dihydroxyvitamin D3 and vitamin D3
on the expression of the vitamin d receptor in human skeletal muscle cells.
Calcif Tissue Int, 2015. 96(3): p. 256-63.

71.

Sato, Y., et al., Changes in the supporting muscles of the fractured hip in
elderly women. Bone, 2002. 30(1): p. 325-30.

72.

Shaw, C.S., D.A. Jones, and A.J. Wagenmakers, Network distribution of
mitochondria and lipid droplets in human muscle fibres. Histochem Cell
Biol, 2008. 129(1): p. 65-72.

73.

Bosma, M., Lipid droplet dynamics in skeletal muscle. Exp Cell Res, 2016.
340(2): p. 180-6.

74.

Haus, J.M., et al., Intramyocellular lipid content and insulin sensitivity are
increased following a short-term low-glycemic index diet and exercise
intervention. Am J Physiol Endocrinol Metab, 2011. 301(3): p. E511-6.

75.

He, J., B.H. Goodpaster, and D.E. Kelley, Effects of weight loss and
physical activity on muscle lipid content and droplet size. Obes Res, 2004.
12(5): p. 761-9.

76.

Pourteymour, S., et al., Perilipin 4 in human skeletal muscle: localization
and effect of physical activity. Physiol Rep, 2015. 3(8).

77.

Dube, J.J., et al., Exercise-induced alterations in intramyocellular lipids
and insulin resistance: the athlete's paradox revisited. Am J Physiol
Endocrinol Metab, 2008. 294(5): p. E882-8.

78.

Pruchnic, R., et al., Exercise training increases intramyocellular lipid and
oxidative capacity in older adults. Am J Physiol Endocrinol Metab, 2004.
287(5): p. E857-62.

184

79.

de la Maza, M.P., et al., Central obesity and not age increases skeletal
muscle lipids, without influencing lean body mass and strength. Nutr Hosp,
2015. 31(3): p. 1134-41.

80.

Choi, S.J., et al., Intramyocellular Lipid and Impaired Myofiber Contraction
in Normal Weight and Obese Older Adults. J Gerontol A Biol Sci Med Sci,
2016. 71(4): p. 557-64.

81.

Jefferson, G., Calcitriol Favorably Alters Lipid Partitioning Within Skeletal
Muscle Cells: 2665 Board #188 June 3, 9: 30 AM - 11: 00 AM. Med Sci
Sports Exerc, 2016. 48(5 Suppl 1): p. 744.

82.

Gallagher, D., et al., Adipose tissue in muscle: a novel depot similar in
size to visceral adipose tissue. Am J Clin Nutr, 2005. 81(4): p. 903-10.

83.

Solomon, T.P., et al., A low-glycemic diet lifestyle intervention improves fat
utilization during exercise in older obese humans. Obesity (Silver Spring),
2013. 21(11): p. 2272-8.

84.

Velan, S.S., et al., Distinct patterns of fat metabolism in skeletal muscle of
normal-weight, overweight, and obese humans. Am J Physiol Regul Integr
Comp Physiol, 2008. 295(4): p. R1060-5.

85.

Hogrel, J.Y., et al., NMR imaging estimates of muscle volume and
intramuscular fat infiltration in the thigh: variations with muscle, gender,
and age. Age (Dordr), 2015. 37(3): p. 9798.

86.

Gilsanz, V., et al., Vitamin D status and its relation to muscle mass and
muscle fat in young women. J Clin Endocrinol Metab, 2010. 95(4): p.
1595-601.

87.

Kakehi, S., et al., Increased intramyocellular lipid/impaired insulin
sensitivity is associated with altered lipid metabolic genes in muscle of
high responders to a high-fat diet. Am J Physiol Endocrinol Metab, 2016.
310(1): p. E32-40.

88.

Corcoran, M.P., S. Lamon-Fava, and R.A. Fielding, Skeletal muscle lipid
deposition and insulin resistance: effect of dietary fatty acids and exercise.
Am J Clin Nutr, 2007. 85(3): p. 662-77.

89.

Jans, A., et al., PUFAs acutely affect triacylglycerol-derived skeletal
muscle fatty acid uptake and increase postprandial insulin sensitivity. Am
J Clin Nutr, 2012. 95(4): p. 825-36.

90.

St-Onge, M.P., et al., Intramyocellular lipid content is lower with a low-fat
diet than with high-fat diets, but that may not be relevant for health. Am J
Clin Nutr, 2007. 86(5): p. 1316-22.

185

91.

Putti, R., et al., Skeletal Muscle Mitochondrial Bioenergetics and
Morphology in High Fat Diet Induced Obesity and Insulin Resistance:
Focus on Dietary Fat Source. Front Physiol, 2015. 6: p. 426.

92.

Lanza, I.R., et al., Influence of fish oil on skeletal muscle mitochondrial
energetics and lipid metabolites during high-fat diet. Am J Physiol
Endocrinol Metab, 2013. 304(12): p. E1391-403.

93.

Howley, E.T. and D.L. Thompson, Fitness Professional’s Handbook 6ed.
2012, Champaign, IL: Human Kinetics.

94.

McCormack, S.E., et al., Effects of exercise and lifestyle modification on
fitness, insulin resistance, skeletal muscle oxidative phosphorylation and
intramyocellular lipid content in obese children and adolescents. Pediatr
Obes, 2014. 9(4): p. 281-91.

95.

Rouffet, D., et al., Intramyocellular lipid variations in active older men:
relationship with aerobic fitness. Acta Physiol (Oxf), 2013. 207(3): p. 51623.

96.

Frontera, W.R. and J. Ochala, Skeletal muscle: a brief review of structure
and function. Calcif Tissue Int, 2015. 96(3): p. 183-95.

97.

Heymsfield, S.B., et al., Assessing skeletal muscle mass: historical
overview and state of the art. J Cachexia Sarcopenia Muscle, 2014. 5(1):
p. 9-18.

98.

Oterdoom, L.H., et al., Urinary creatinine excretion, an indirect measure of
muscle mass, is an independent predictor of cardiovascular disease and
mortality in the general population. Atherosclerosis, 2009. 207(2): p. 53440.

99.

U.S. Department of Health and Human Services and National Institue of
Biomedical Imaging and Bioengineering. Magnetic Resonance Imaging.
2016.

100.

Henry, B., et al., Hybrid diffuse optical techniques for continuous
hemodynamic measurement in gastrocnemius during plantar flexion
exercise. J Biomed Opt, 2015. 20(12): p. 125006.

101.

Kirkwood, R.N., et al., Decreased gastrocnemius temporal muscle
activation during gait in elderly women with history of recurrent falls. Gait
Posture, 2011. 34(1): p. 60-4.

102.

Petrella, R.J., et al., Comparison of twitch potentiation in the
gastrocnemius of young and elderly men. Eur J Appl Physiol Occup
Physiol, 1989. 58(4): p. 395-9.

186

103.

Williams, S.E., et al., Quantitative effects of inclusion of fat on muscle
diffusion tensor MRI measurements. J Magn Reson Imaging, 2013. 38(5):
p. 1292-7.

104.

Shang, Y., K. Gurley, and G. Yu, Diffuse Correlation Spectroscopy (DCS)
for Assessment of Tissue Blood Flow in Skeletal Muscle: Recent
Progress. Anat Physiol, 2013. 3(2): p. 128.

105.

Yu, G., et al., Near-Infrared Diffuse Correlation Spectroscopy for
Assessment of Tissue Blood Flow, in Handbook of Biomedical Optics.
2011, CRC Press Taylor & Francis Group: Florida. p. 195-216.

106.

Mesquita, R.C., et al., Diffuse optical characterization of an exercising
patient group with peripheral artery disease. J Biomed Opt, 2013. 18(5): p.
57007.

107.

Shang, Y., et al., Noninvasive optical characterization of muscle blood
flow, oxygenation, and metabolism in women with fibromyalgia. Arthritis
Res Ther, 2012. 14(6): p. R236.

108.

Mayo Clinic Staff. Diseases and Conditions: Fibromyalgia Definition. 2016.

109.

Gurley, K., Y. Shang, and G. Yu, Noninvasive optical quantification of
absolute blood flow, blood oxygenation, and oxygen consumption rate in
exercising skeletal muscle. J Biomed Opt, 2012. 17(7): p. 075010.

110.

Mademli, L. and A. Arampatzis, Effect of voluntary activation on agerelated muscle fatigue resistance. J Biomech, 2008. 41(6): p. 1229-35.

111.

Center for Disease Control, National Health and Nutrition Examination
Survey (NHANES) Anthropometry Procedures Manual. 2007.

112.

World Health Organization. BMI Classification. 2016.

113.

Center for Disease Control, National Health and Nutrition Examination
Survey (NHANES) Health Tech/Blood Pressure Procedures Manual.
2009.

114.

American College of Sports Medicine and L.S. Pescatello, ACSM's
Guidelines for Exercise Testing and Prescription 9ed. 2014, Philadelphia:
Wolters Kluwer/Lippincott Williams & Wilkins Health.

115.

University of Kentucky, Obtaining Blood Specimens Policy # NL08-02.

116.

Hamilton, C.M., et al., The PhenX Toolkit: get the most from your
measures. Am J Epidemiol, 2011. 174(3): p. 253-60.

187

117.

Moshfegh, A.J., et al., The US Department of Agriculture Automated
Multiple-Pass Method reduces bias in the collection of energy intakes. Am
J Clin Nutr, 2008. 88(2): p. 324-32.

118.

University of Minnesota. Nutrition Coordinating Center. 2016; Available
from: http://www.ncc.umn.edu/.

119.

Blanton, C.A., et al., The USDA Automated Multiple-Pass Method
accurately estimates group total energy and nutrient intake. J Nutr, 2006.
136(10): p. 2594-9.

120.

Conway, J.M., L.A. Ingwersen, and A.J. Moshfegh, Accuracy of dietary
recall using the USDA five-step multiple-pass method in men: an
observational validation study. J Am Diet Assoc, 2004. 104(4): p. 595-603.

121.

University of Minnesota. Information for Grant Writers: Description of 24hour Dietary and Supplement Recall Features of NDSR. 2016.

122.

Metcalf, B.S., et al., Technical reliability of the CSA activity monitor: The
EarlyBird Study. Med Sci Sports Exerc, 2002. 34(9): p. 1533-7.

123.

Santos-Lozano, A., et al., Actigraph GT3X: validation and determination of
physical activity intensity cut points. Int J Sports Med, 2013. 34(11): p.
975-82.

124.

Brooks, G.A., T.D. Fahey, and B. K.M., Exercise Physiology: Human
Bioenergetics and Its Applications. 4 ed. 2005, Boston: McGraw Hill.

125.

Center for Disease Control. How much physical activity do older adults
need? 2015.

126.

Washburn, R.A., et al., The Physical Activity Scale for the Elderly (PASE):
development and evaluation. J Clin Epidemiol, 1993. 46(2): p. 153-62.

127.

Dinger, M.K., et al., Stability and convergent validity of the Physical
Activity Scale for the Elderly (PASE). J Sports Med Phys Fitness, 2004.
44(2): p. 186-92.

128.

Public Health Agency of Canada and the Canadian Society for Exercise
Physiology, Physical Activity Readiness Questionnaire [PAR-Q], in
Minister of Public Works and Government Services Canada. 2007.

129.

Balady, G.J., et al., Recommendations for cardiovascular screening,
staffing, and emergency policies at health/fitness facilities. Circulation,
1998. 97(22): p. 2283-93.

188

130.

Dite, W. and V.A. Temple, A clinical test of stepping and change of
direction to identify multiple falling older adults. Arch Phys Med Rehabil,
2002. 83(11): p. 1566-71.

131.

Heyward, V.H., Advanced fitness assessment and exercise prescription.
2010, Champaign, IL: Human Kinetics.

132.

Erlandson, M.C., et al., Muscle analysis using pQCT, DXA and MRI. Eur J
Radiol, 2016. 85(8): p. 1505-11.

133.

Nadrljanski, M.M. Computed tomography. 2016; Available from:
radiopaedia.org.

134.

Rasband, W.S. ImageJ. 2016; Available from: http://imagej.nih.gov/ij/.

135.

Pfeifer, M., et al., Effects of a short-term vitamin D and calcium
supplementation on body sway and secondary hyperparathyroidism in
elderly women. J Bone Miner Res, 2000. 15(6): p. 1113-8.

136.

Sato, Y., et al., Low-dose vitamin D prevents muscular atrophy and
reduces falls and hip fractures in women after stroke: a randomized
controlled trial. Cerebrovasc Dis, 2005. 20(3): p. 187-92.

137.

Harris, P.A., et al., Research electronic data capture (REDCap)--a
metadata-driven methodology and workflow process for providing
translational research informatics support. J Biomed Inform, 2009. 42(2):
p. 377-81.

138.

President's Council on Fitness Sports Nutriton. Facts & Statistics: Physical
Activity. 2016; Available from: https://www.fitness.gov/resourcecenter/facts-and-statistics/#footnote-23.

139.

Van Pelt, R.E., et al., Waist circumference vs body mass index for
prediction of disease risk in postmenopausal women. Int J Obes Relat
Metab Disord, 2001. 25(8): p. 1183-8.

140.

Janssen, I., P.T. Katzmarzyk, and R. Ross, Waist circumference and not
body mass index explains obesity-related health risk. Am J Clin Nutr,
2004. 79(3): p. 379-84.

141.

Coen, P.M. and B.H. Goodpaster, Role of intramyocelluar lipids in human
health. Trends Endocrinol Metab, 2012. 23(8): p. 391-8.

142.

Groen, B.B., et al., Skeletal muscle capillary density and microvascular
function are compromised with aging and type 2 diabetes. J Appl Physiol
(1985), 2014. 116(8): p. 998-1005.

189

143.

Lee, D.H., et al., Deeper penetration of erythrocytes into the endothelial
glycocalyx is associated with impaired microvascular perfusion. PLoS
One, 2014. 9(5): p. e96477.

144.

Marcus, R.L., et al., Skeletal muscle fat infiltration: impact of age,
inactivity, and exercise. J Nutr Health Aging, 2010. 14(5): p. 362-6.

145.

McLellan, S.A. and T.S. Walsh, Oxygen delivery and haemoglobin. British
Journal of Anaesthesia, 2004. 4(4).

146.

Huang, G., et al., Controlled endurance exercise training and VO2max
changes in older adults: a meta-analysis. Prev Cardiol, 2005. 8(4): p. 21725.

147.

DeLorey, D.S., J.M. Kowalchuk, and D.H. Paterson, Effect of age on O(2)
uptake kinetics and the adaptation of muscle deoxygenation at the onset
of moderate-intensity cycling exercise. J Appl Physiol (1985), 2004. 97(1):
p. 165-72.

148.

Jones, S., et al., Recent developments in near-infrared spectroscopy
(NIRS) for the assessment of local skeletal muscle microvascular function
and capacity to utilise oxygen. Artery Research, 2016. 16: p. 25-33.

149.

Crane, J.D., et al., The effect of aging on human skeletal muscle
mitochondrial and intramyocellular lipid ultrastructure. J Gerontol A Biol
Sci Med Sci, 2010. 65(2): p. 119-28.

150.

United States Department of Agriculture and United States Department of
Health and Human Services, Dietary Guidelines for Americans 2010. U.S.
Government Printing Office: Washington, DC.

151.

Nettleton, J.A., P. Legrand, and R.P. Mensink, ISSFAL 2014 Debate: It Is
Time to Update Saturated Fat Recommendations. Ann Nutr Metab, 2015.
66(2-3): p. 104-8.

152.

Scioli, M.G., et al., Ageing and microvasculature. Vasc Cell, 2014. 6: p.
19.

153.

Marengi, N., et al., Feasibility of Using Near Infrared Spectroscopy in
Determining VO2 for Preoperative Risk Assessment, in Senior Scholars
Program. 2009: University of Massachusetts Medical School.

154.

Kuk, J.L., et al., Age-related changes in total and regional fat distribution.
Ageing Res Rev, 2009. 8(4): p. 339-48.

155.

Hess, D.R., Retrospective Studies and Chart Reviews. Respiratory Care,
2004. 49(10): p. 1171-74.

190

Vita
Maja Redzic
Vita
Department of Pharmacology and Nutritional Sciences
University of Kentucky
Education
2006-2010
2010-2011

Michigan State University, East Lansing, Michigan
Bachelor of Science, Nutritional Sciences
University of Kentucky, Lexington Kentucky
Master of Science in Nutritional Sciences

RESEARCH
2012-2016 Graduate Research Assistant, University of Kentucky
Title: Vitamin D Contribution to Muscle Metabolic Function in
Aged Adults
Mentor: D. Travis Thomas, Clinical Sciences, College of
Health Sciences
GRANTS AND AWARDS
2006
Academic Competitiveness, Michigan State University
2006-2008
Michigan MEAP Scholar, Michigan State University
2009-2010
Federal National SMART Grant, Michigan State University
2010
Bradford-Adams Endowed Scholarship for Chemistry, MSU
2013
1st place: Poster Presentation: Epidemiology Research of
Vitamins and Minerals in the Vitamin and Mineral Research
Interest Section of the American Society of Nutrition at the
Experimental Biology Conference, Boston, MA
2011-2014
Thornton Scholarship, University of Kentucky
2014
Tracy Farmer Institute for Sustainability and the Environment
Promoting Healthy Lifestyle in Targeted Minority Setting,
University of Kentucky
2014
Nutrition Intervention to Reduce Symptoms in Patients with
Advanced Heart Failure, Lennie (PI), University of Kentucky
2014
Vitamin D Contribution to Muscle Metabolic Function in Aged
Adults, Thomas (PI), University of Kentucky
2015
Human Health Sciences Certificate of Appreciation in
Mentorship, University of Kentucky
2015
College of Health Sciences' Robinson Graduate Award for
Research Creativity, University of Kentucky

191

2014-2016

T32 Nutrition and Oxidative Stress Training Fellowship,
University of Kentucky

PUBLICATIONS
2013

2013

2014
2014

2014

2015

Redzic M, Lewis RM, Thomas DT. Relationship between 25hydoxyvitamin D, muscle strength, and incidence of injury in
healthy adults: a systematic review. Nutrition Research.
2013;33(4):251-8.
Lewis RM, Redzic M, Thomas DT. The effects of season-long
vitamin D supplementation on collegiate swimmers and divers.
International Journal of Sport Nutrition and Exercise Metabolism.
2013;23(5):431-40
Thomas D, Redzic M. Vitamin D and Athletes, Part I: A Growing
Interest. Athletic Training and Sports Health Care. 2014; 6(1):5-6.
Thomas DT, Redzic M. Vitamin D and Athletes, Part II: Vitamin D
Relationship to Injury & Clinical Recommendations. Athletic
Training and Sports Health Care 2014; 6:(2):53-54
Redzic M, DK Powell, DT Thomas. Vitamin D Status is Related to
Intramyocellular Lipid in Older Adults. Endocrine 2014; 47(3):85461
Cassity EP, Redzic M, Teager CR, Thomas DT. The effect of body
composition and BMI on 25(OH)D response in vitamin Dsupplemented athletes. European Journal of Sport Science. 2015;
1-7.

ABSTRACTS
2012
Lewis RM, Redzic M, Shores PB, Thomas DT. 25(OH)D Status is
not Related to Bone Mineral Density or Inflammatory Cytokines in
Collegiate Athletes. Medicine & Science in Sport & Exercise, 2012;
44(5)S pp. S721.
2013
Redzic M, Powell, DK, Thomas, DT. Vitamin D status is related to
intramyocellular lipid in older adults. The Journal of the Federation
of American Societies for Experimental Biology 2013; 27:635.7.
2013
Lewis RM, Redzic M, Thomas DT. The Effects of Season-long
Vitamin D Supplementation on Collegiate Swimmers and Divers.
Center for Clinical and Translational Sciences, University of
Kentucky, 2013.
2014
Achenjang NS, Pampati S, Redzic M, Lutz CT, Powell DK, Thomas
DT. Vitamin D Status, Physical Function, and Muscle Lipid in Aged
Adults. National Conference on Undergraduate Research,
University of Kentucky, 2014.
2014
Redzic M, DK Powell, CT Lutz, DT Thomas. Differences in
extramyocellular lipid and physical function in older adults with
sufficient and insufficient vitamin D status. Journal of the Federation
of American Societies for Experimental Biology 2014; 28:260.2.

192

2014

2015

2015

2015

2016

2016

2016

2016

2016

Redzic M, Cassity E, Hawes C, Thomas DT, Bruckner G. A Pilot
Study Promoting Healthy Lifestyles in a Targeted Minority Setting.
Tracy Farmer Institute for Sustainability and the Environment 4th
Annual Research Showcase, University of Kentucky, 2014.
Teager C, Redzic M, Cassity E, Thomas DT. Differences in Bone
Turnover and 25(OH)D Change in Indoor Athletes. The Journal of
the Federation of American Societies for Experimental Biology
2015; 29:733.2.
Redzic M, Thomas DT. The Contribution of Dietary Intake Patterns
and Physical Activity Levels to Muscle Lipid in Aged Individuals.
Center for Clinical and Translational Sciences Conference,
University of Kentucky, 2015.
Redzic M, Thomas DT. The Contribution of Dietary Intake Patterns
and Physical Activity Levels to Muscle Lipid in Aged Individuals.
Barnstable Brown Obesity and Diabetes Research Day, University
of Kentucky, 2015.
Thomas DT, Redzic M, Zhao M, White M, and Yu G. Changes in
Muscle Lipid and rVO2 following Vitamin D Repletion and Aerobic
Training in Aged Individuals. American College of Sports Medicine
Conference, 2016.
Redzic M, Mitchell LV, Thomas DT. Unsaturated to Saturated Fatty
Acid Intake Ratio is Inversely Associated with Intramyocellular Lipid
in Healthy, Aged Individuals. Center for Clinical and Translational
Sciences Conference, University of Kentucky, 2016.
Redzic M, Mitchell LV, Thomas DT. Unsaturated to Saturated Fatty
Acid Intake Ratio is Inversely Associated with Intramyocellular Lipid
in Healthy, Aged Individuals. Barnstable Brown Obesity and
Diabetes Research Day, University of Kentucky, 2016.
Redzic M, Mitchell LV, Thomas DT. The Relationship between Fat
Intake, Physical Activity, and Muscle Lipid in Aged Individuals.
American College of Sports Medicine Conference, 2016.
McLean H, Redzic M, Thomas DT. Higher Unsaturated Fatty Acid
Intake and Aerobic Training are Related with
Lower Intramyocellular Lipid in Older Adults. Posters-at-the-Capitol
in Frankfort, KY 2016

SEMINAR PRESENTATIONS
2013

2013

Vitamin D Contribution to Muscle Metabolic Function in the Elderly.
Muscle Forum for the Center of Muscle Biology, University of
Kentucky
Vitamin D Contribution to Muscle Metabolic Function in the Elderly.
Graduate Center For Nutritional Sciences Seminar, University of
Kentucky

193

2014

2015

2015

2016

Differences in extramyocellular lipid and physical function in older
adults with sufficient and insufficient vitamin D status. Experimental
Biology Conference, San Diego, CA
The relationship between vitamin D and muscle health. Department
of Pharmacology and Nutritional Sciences Seminar Series,
University of Kentucky
Influence of vitamin D repletion, diet composition, and physical
activity on muscle lipid distribution in healthy aged individuals.
Muscle Forum for the Center of Muscle Biology, University of
Kentucky
Influence of vitamin D repletion, diet composition, and physical
activity on muscle lipid distribution in healthy aged individuals.
Department of Pharmacology and Nutritional Sciences Seminar
Series, University of Kentucky

MENTORING/TEACHING ACTIVITY
2011-2016
2016
2016
2015
2015

Taught and mentored 9 undergraduate and 16 master’s students,
University of Kentucky
Nutrition Counseling and Interviewing Techniques, Wellness and
Sports Nutrition (NS 605), University of Kentucky
Nutritional Consultation lecture and lab, Nutrition and Physical
Fitness (KHP 240), University of Kentucky
Seminar in Interprofessional Healthcare (HHS356), University of
Kentucky
Nutrition Counseling and Interviewing Techniques, Wellness and
Sports Nutrition (NS 605), University of Kentucky

194

